{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:29:36Z","timestamp":1793233776127,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000213.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T00:00:00Z","timestamp":1406592000000}}],"reference-count":876,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000213.pub3","type":"journal-article","created":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T09:31:42Z","timestamp":1406626302000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":335,"title":["Thrombolysis for acute ischaemic stroke"],"prefix":"10.1002","volume":"2016","author":[{"given":"Joanna M","family":"Wardlaw","sequence":"first","affiliation":[{"name":"University of Edinburgh; Centre for Clinical Brain Sciences; The Chancellor's Building 49 Little France Crescent Edinburgh UK EH16 4SB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Murray","sequence":"additional","affiliation":[{"name":"Danderyd Hospital; Department of Clinical Sciences, Karolinska Institutet; Stockholm Sweden SE-182 88"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eivind","family":"Berge","sequence":"additional","affiliation":[{"name":"Oslo University Hospital; Department of Internal Medicine; Oslo Norway NO-0407"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J","family":"del Zoppo","sequence":"additional","affiliation":[{"name":"University of Washington; Department of Medicine (Division of Hematology), Department of Neurology; 325 Ninth Avenue Box 359756 Seattle Washington USA 98104"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,29]]},"reference":[{"issue":"1-2","key":"10.1002\/14651858.CD000213.pub3-BIB0003|cit1","first-page":"121","article-title":"Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis","volume":"113","author":"Abe","year":"1986","journal-title":"Folia Haematologica - Leipzig"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0004|cit2","first-page":"359","article-title":"Thrombolytic therapy for cerebral infarction","volume":"3","author":"Abe","year":"1984","journal-title":"International Angiology"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0001|cit3","first-page":"161","article-title":"Effect of oral urokinase and its clinical application","volume":"13","author":"Abe","year":"1982","journal-title":"The New Instanbul Contribution to Clinical Science"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0002|cit4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2491\/jjsth1970.12.321","article-title":"Clinical evaluation for efficacy of tissue cultured urokinase (TCUK) on cerebral thrombosis by means of multi-center double-blind study","volume":"12","author":"Abe","year":"1981","journal-title":"Blood & Vessel"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0005|cit5","first-page":"1027","article-title":"Basic and clinical studies on oral urokinase and lysyl-plasminogen","volume":"25","author":"Naito","year":"1984","journal-title":"Rinsho Ketsueki"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0006|cit6","first-page":"128","article-title":"Australian streptokinase trial: clinical and CT outcome predictors","volume":"6","author":"Davis","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0007|cit7","first-page":"183","article-title":"ASK trial: predictors of good outcome","volume":"6","author":"Donnan","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0008|cit8","first-page":"182","article-title":"ASK trial: risk factors for poor outcome","volume":"6","author":"Donnan","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.1996.03540120039031","article-title":"Streptokinase for acute ischemic stroke with relationship to time of administration","volume":"276","author":"Donnan","year":"1996","journal-title":"JAMA"},{"issue":"8949","key":"10.1002\/14651858.CD000213.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(95)90484-0","article-title":"Trials of streptokinase in severe acute ischaemic stroke","volume":"345","author":"Donnan","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0011|cit11","first-page":"80","article-title":"Australian Streptokinase Trial (ASK)","volume-title":"Thrombolytic therapy in acute ischaemic stroke II","author":"Donnan","year":"1993"},{"issue":"8966","key":"10.1002\/14651858.CD000213.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(95)92689-5","article-title":"Streptokinase in acute ischemic stroke","volume":"346","author":"Donnan","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0013|cit13","unstructured":"Gilligan A Markus R Read S Srikanth V Hirano T Chambers B Early CT changes do not predict parenchymal haemorrhage following streptokinase therapy in acute stroke Abstracts from the 6th International Symposium on Acute Stroke and Thrombolytic Therapy; 25-29 November 2000; Hamilton Island, Australia 2001"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/str.32.suppl_1.370-d","article-title":"Early CT changes do not predict parenchymal haemorrhage following streptokinase therapy in acute stroke","volume":"32","author":"Gilligan","year":"2001","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.50.3.626","article-title":"Streptokinase in acute stroke: effect on reperfusion and recanalisation","volume":"50","author":"Yasaka","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0016|cit16","first-page":"659","article-title":"Clinical utility of urokinase in the treatment of acute stage cerebral thrombosis: Multi-center double blind study in comparison with placebo","volume":"13","author":"Atarashi","year":"1985","journal-title":"Clinical Evaluation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0017|cit17","first-page":"126","article-title":"The ATLANTIS rtPA (alteplase) acute stroke trial: final results","volume":"9","author":"Albers","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0018|cit18","first-page":"234","article-title":"The ATLANTIS rt-PA (alteplase) acute stroke trial - final results","volume":"30","author":"Clark","year":"1999","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.STR.31.4.811","article-title":"The rtPA (alteplase) 0- to 6- hour acute stroke trial, part A (A027g). Results of a double-blind, placebo-controlled, multicentre study. Thrombolytic Therapy in Acute Ischaemic Stroke Study Investigators","volume":"31","author":"Clark","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/01.STR.30.2.389","article-title":"Evaluation of early computed tomographic findings in acute ischaemic stroke","volume":"30","author":"Marks","year":"1999","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0021|cit21","first-page":"126","article-title":"The ATLANTIS rtPA (alteplase) acute stroke trial: final results","volume":"9","author":"Albers","year":"1999","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/hs0202.102599","article-title":"The ATLANTIS trial: Results for patients treated within three hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.","volume":"33","author":"Albers","year":"2002","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0023|cit23","first-page":"234","article-title":"The ATLANTIS rt-PA (alteplase) acute stroke trial - final results","volume":"30","author":"Clark","year":"1999","journal-title":"Stroke"},{"issue":"21","key":"10.1002\/14651858.CD000213.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (alteplase) for ischaemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomised controlled trial","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0025|cit25","unstructured":"Kent D Ruthazer R Selker HP Do some patients benefit from rt-PA treatment for acute ischaemic stroke even when treated more than 3 hours after the onset of symptoms? Abstracts of the 7th International Symposium on Thrombolysis and Acute Ischaemic Stroke; 2002 May 27-28; Lyon 2002 79"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0026|cit26","first-page":"34","article-title":"Are asymptomatic intracranial hemorrhages really innocuous?","volume":"16","author":"Kent","year":"2003","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.STR.0000051506.43212.8B","article-title":"Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?","volume":"34","author":"Kent","year":"2003","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/01.STR.30.2.389","article-title":"Evaluation of early computed tomographic findings in acute ischaemic stroke","volume":"30","author":"Marks","year":"1999","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0029|cit29","first-page":"188","article-title":"Australian Urokinase Stroke Trial","volume":"6","author":"Davis","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0030|cit30","unstructured":"Donnan G Australian urokinase stroke trial - AUST www.strokecenter.org\/trials\/list 2001"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0031|cit31","first-page":"25","article-title":"Australian urokinase stroke trial (AUST)","volume":"6","author":"Donnan","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0032|cit32","unstructured":"Gerraty RP Mitchell PJ Fitt G Tress BM Donnan GA Davis SM Intra-arterial thrombolysis for basilar artery occlusion: Australian urokinase stroke study phase II results Programme and Abstract Book of the Stroke Society of Australasia; 1995 Annual Scientific Meeting; 1995 Oct 4-6; Melbourne 1995"},{"issue":"1-2","key":"10.1002\/14651858.CD000213.pub3-BIB0033|cit33","first-page":"A1","article-title":"Preliminary results of the AUST\/POST study","volume":"34","author":"Macleod","year":"2004","journal-title":"Internal Medicine Journal"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000086121","article-title":"Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke","volume":"20","author":"Macleod","year":"2005","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000108174","article-title":"Thrombolysis in the vertebrobasilar circulation: the Australian urokinase stroke trial","volume":"7","author":"Mitchell","year":"1997","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0036|cit36","unstructured":"National Stroke Research Institute Preliminary results of the Australian urokinase stroke study\/posterior circulation thrombolysis study Powerpoint presentation"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0039|cit37","unstructured":"Intravenous thrombolysis with urokinase for acute cerebral infarctions. The study group of a 5 year National Project of the People's Republic of China, conducted by Qingtang Chen and Maolin He Chinese Journal of Neurology 2002"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0037|cit38","first-page":"7","article-title":"Intravenous thrombolysis with urokinase for acute cerebral infarctions","volume":"7","author":"Chen","year":"2001","journal-title":"Hong Kong Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0038|cit39","first-page":"210","article-title":"Intravenous thrombolysis with urokinase for acute cerebral infarctions","volume":"35","author":"Cooperating Group for National 95's Project","year":"2002","journal-title":"Chinese Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0040|cit40","first-page":"S7","article-title":"Intravenous thrombolysis with urokinase for acute cerebral infarctions","volume":"11 Suppl 1","author":"Wang","year":"2004","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0041|cit41","unstructured":"Conroy MM Bat saliva drug may widen treatment window for stroke www.medscape.com"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0042|cit42","first-page":"Abst. 2595","article-title":"Vascular occlusion as an imaging biomarker for selecting acute ischemic stroke patients for treatment with desmoteplase","volume":"43","author":"Fiebach","year":"2012","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/STROKEAHA.111.642322","article-title":"Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase","volume":"43","author":"Fiebach","year":"2012","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0045|cit44","unstructured":"Furlan AJ Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS) www.clinicaltrials.gov\/ct2\/show\/NCT00638248?term=Dose+Escalation+of+Desmoteplase+in+Acute+Ischemic+Stroke+%28DEDAS%29&rank=1"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0044|cit45","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.STR.0000217403.66996.6d","article-title":"Dose Escalation of Desmoteplase for Acute Ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset","volume":"37","author":"Furlan","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0046|cit46","first-page":"36","article-title":"Desmoteplase in acute stroke - an integrated analysis of two phase II clinical trials","volume":"1 Suppl 1","author":"Hacke","year":"2006","journal-title":"International Journal of Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0047|cit47","first-page":"656","article-title":"Recombinant desmodus salivary plasminogen activator (desmoteplase) in acute ischemic stroke","volume":"37","author":"Pugsley","year":"2006","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0049|cit48","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/STROKEAHA.111.642348","article-title":"Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection","volume":"43","author":"Warach","year":"2012","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0048|cit49","first-page":"Abst.2600","article-title":"Refinement of the MR diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the Desmoteplase in Acute Stroke Trials","volume":"43","author":"Warach","year":"2012","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0050|cit50","first-page":"567","article-title":"Technology evaluation: desmoteplase, PAION\/Forest","volume":"6","author":"Debens","year":"2004","journal-title":"Current Opinion on Molecular Therapeutics"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0052|cit51","doi-asserted-by":"crossref","first-page":"A2595","DOI":"10.1161\/STROKEAHA.111.642322","article-title":"Vascular occlusion as an imaging biomarker for selecting acute ischemic stroke patients for treatment with desmoteplase","volume":"43","author":"Fiebach","year":"2012","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0051|cit52","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/STROKEAHA.111.642322","article-title":"Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase","volume":"43","author":"Fiebach","year":"2012","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0055|cit53","unstructured":"Hacke W Desmoteplase in Acute Ischemic Stroke (DIAS) clinicaltrials.gov\/ct2\/show\/NCT00638781?term=Desmoteplase+in+Acute+Ischemic+Stroke+%28DIAS%29&rank=1"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0056|cit54","unstructured":"Hacke W Results of the phase II study DIAS Powerpoint presentation"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0057|cit55","unstructured":"Hacke W The DIAS study: results of a phase II, MRI-based dose finding study of desmoteplase in acute stroke XVIIth International Congress on Fibrinolysis and Proteolysis; 2004 Mar 21-15; Melbourne 2004"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0053|cit56","first-page":"69","article-title":"The results of the joint analysis of two phase II trials on desmoteplase in acute ischemic stroke with treatment 3 to 9 hours after stroke onset","volume":"19","author":"Hacke W for the DIAS and DEDAS Steering Committees and Investigators","year":"2005","journal-title":"Cerebrovascular Diseases"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0054|cit57","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.STR.0000149938.08731.2c","article-title":"The Desmoteplase In Acute ischemic Stroke trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase","volume":"36","author":"Hacke","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0058|cit58","unstructured":"Hacke W Desmoteplase in acute ischemic stroke (DIAS) The American Stroke Association 28th International Stroke Conference; 2003 Feb 13-15; Phoenix 2003 CTP14"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0059|cit59","first-page":"S62","article-title":"Combined safety analysis of desmoteplase in acute ischemic stroke 3 to 9 hours after stroke symptom onset from two independent Phase II studies (DIAS and DEDAS)","volume":"238 Suppl 1","author":"Lees","year":"2005","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0060|cit60","unstructured":"PAION DIAS www.paion.de\/"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1747-4949.2012.00910.x","article-title":"The Desmoteplase in Acute Ischemic Stroke (DIAS) clinical trial program","volume":"7","author":"Kummer","year":"2012","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0062|cit62","unstructured":"Warach S for the DIAS Steering Committee Early reperfusion related to clinical response in DIAS: phase II, randomized, placebo-controlled dose finding trial of IV desmoteplase 3-9 hours from onset in patients with diffusion-perfusion mismatch www.abstractsonline.com\/arch\/RecordPrintView.aspx?LookupKey=12345&RecordID=11015"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0063|cit63","first-page":"409","article-title":"Randomized, placebo-controlled trial of IV desmoteplase 3-9 hours from stroke onset in patients with diffusion-perfusion mismatch: early reperfusion related to dose and therapeutic response","volume":"11","author":"Warach S for the DIAS Steering Committee","year":"2004","journal-title":"Proceedings of the International Society of Magnetic Resonance Medicine"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"A2600","DOI":"10.1161\/STROKEAHA.111.642348","article-title":"Refinement of the MR diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the Desmoteplase in Acute Stroke Trials","volume":"43","author":"Warach","year":"2012","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/STROKEAHA.111.642348","article-title":"Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials","volume":"43","author":"Warach","year":"2012","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0066|cit66","unstructured":"Eng P Spielhofen A DIAS-2. Desmoteplase in acute ischemic stroke-2 www.strokecenter.org\/trials\/TrialDetail.aspx?tid=515"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0067|cit67","first-page":"165","article-title":"Vascular occlusion as imaging biomarker in selecting acute ischaemic stroke patients for treatment with desmoteplase","volume":"31","author":"Fiebach","year":"2011","journal-title":"Cerebrovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"A2595","DOI":"10.1161\/STROKEAHA.111.642322","article-title":"Vascular occlusion as an imaging biomarker for selecting acute ischemic stroke patients for treatment with desmoteplase","volume":"43","author":"Fiebach","year":"2012","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/STROKEAHA.111.642322","article-title":"Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase stroke","volume":"43","author":"Fiebach","year":"2012","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0070|cit70","unstructured":"Forest Laboratories Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2) www.clinicaltrials.gov\/ct2\/show\/NCT00111852?term=DIAS-2&rank=1"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0076|cit71","unstructured":"Hacke W DIAS-2: No benefit of desmoteplase in acute ischemic stroke www.medscape.com\/viewarticles\/557663_print"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0072|cit72","first-page":"128","article-title":"The ongoing phase III study of desmoteplase in acute ischemic stroke","volume":"1 Suppl 1","author":"Hacke","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0073|cit73","first-page":"46","article-title":"The ongoing phase III study of desmoteplase in acute ischemic stroke","volume":"1 Suppl 2","author":"Hacke","year":"2006","journal-title":"International Journal of Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0071|cit74","first-page":"54","article-title":"Results from the phase III study of Desmoteplase in Acute Ischemic Stroke trial 2 (DIAS-2)","volume":"23","author":"Hacke","year":"2007","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0074|cit75","doi-asserted-by":"crossref","unstructured":"Hacke W Furlan AJ Al-Rawi Y Davalos A Fiebach JB Gruber F Intravenous desmoteplase in patients with acute ischaemic stroke selected by MR perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study Lancet Neurology 2008 10.1016\/6\/51474-4422(08)70267-9","DOI":"10.1016\/S1474-4422(08)70267-9"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0075|cit76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(08)70267-9","article-title":"Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study","volume":"8","author":"Hacke","year":"2009","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1474-4422(08)70268-0","article-title":"Desmoteplase and imaging science","volume":"8","author":"Hill","year":"2009","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0078|cit78","unstructured":"Jeffrey S DIAS-2 revisited: development of desmoteplase for stroke to continue www.medscape.com\/viewarticle\/565145"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0079|cit79","unstructured":"Jeffrey S DIAS-2 revisited: development of desmoteplase for stroke to continue www.medscape.com\/viewarticle\/565145_print"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0080|cit80","unstructured":"Jeffrey S DIAS-2: No benefit of desmoteplase in acute ischemic stroke www.medscape.com\/viewarticle\/557663_print"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0081|cit81","unstructured":"Jeffrey S DIAS-2: patient enrolment resumes in trial of desmoteplase in stroke www.medscape.com\/viewarticle\/547120"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1161\/STROKEAHA.109.559682","article-title":"Reversing stroke in the 2010s. Lessons from Desmoteplase In Acute ischemic Stroke-2 (DIAS-2)","volume":"40","author":"Liebeskind","year":"2009","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0083|cit83","unstructured":"PAION AG Forest Laboratories Inc DIAS 2. Desmoteplase (INN) in acute ischemic stroke. Assessing treatment within 3-9 hours after onset of stroke symptoms paiondias.01kunden.net"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0086|cit84","unstructured":"Warach S Clinical benefit of desmoteplase treatment in patients with moderate to severe stroke: further results of the DIAS-2 trial Proceedings of the International Stroke Conference; 2008 Feb 20-22; New Orleans American Stroke Association 2008 LB P2"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0084|cit85","doi-asserted-by":"crossref","first-page":"A2600","DOI":"10.1161\/STROKEAHA.111.642348","article-title":"Refinement of the MR diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the Desmoteplase in Acute Stroke Trials","volume":"43","author":"Warach","year":"2012","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0085|cit86","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1161\/STROKEAHA.111.642348","article-title":"Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection","volume":"43","author":"Warach","year":"2012","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1468-1331.1995.tb00074.x","article-title":"European Cooperative Acute Stroke Study (ECASS): (rt-PA - thrombolysis in acute stroke) study design and progress report","volume":"1","author":"Boysen","year":"1995","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.1996.03530370021011","article-title":"Letter to the editor","volume":"275","author":"Ciccone","year":"1996","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1161\/01.STR.30.12.2631","article-title":"Neurological deterioration in acute ischaemic stroke: potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I","volume":"30","author":"D\u00e1valos","year":"1999","journal-title":"Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0090|cit90","first-page":"29","article-title":"Very early identification of lacunar infarcts in the ECASS Study","volume":"7","author":"ECASS Study Group","year":"1997","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0091|cit91","unstructured":"Fieschi C Argentino C Fiorelli M Mau J Roine RO Willig V Frequency and consequences of medical complications of ischaemic stroke The Challenge of Stroke. Lancet Conference; 1999 Oct 15-16; Montreal 1999 35"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0092|cit92","first-page":"14","article-title":"Natural history of ischaemic stroke in ECASS 1 and ECASS II placebo cohorts","volume":"9","author":"Fiorelli","year":"1999","journal-title":"Cerebrovascular Diseases"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/01.STR.30.11.2280","article-title":"Hemorrhagic transformation within 36 hours of a cerebral infarct. Relationships with early clinical deterioration and three month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort","volume":"30","author":"Fiorelli","year":"1999","journal-title":"Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0094|cit94","first-page":"19","article-title":"Cortical extension of the infarction at 24 hours in patients with isolated hypodensity of the lentiform nucleus on 1-6 hour CT: Incidence, predictors and outcome in the ECASS 1 cohort","volume":"8","author":"Fiorelli","year":"1998","journal-title":"Cerebrovascular Diseases"},{"issue":"13","key":"10.1002\/14651858.CD000213.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jama.1995.03530130064029","article-title":"ECASS: Lessons for future thrombolytic stroke trials","volume":"274","author":"Fisher","year":"1996","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/01.STR.29.10.2073","article-title":"Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set. Post hoc analysis of ECASS 1","volume":"29","author":"Hacke","year":"1998","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0098|cit97","first-page":"984","article-title":"Reply to letter to the editor","volume":"275","author":"Hacke","year":"1996","journal-title":"JAMA"},{"issue":"13","key":"10.1002\/14651858.CD000213.pub3-BIB0097|cit98","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)","volume":"274","author":"Hacke","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0099|cit99","first-page":"272","article-title":"rt-PA in acute ischaemic stroke - results from the ECASS three hour cohort","volume":"28","author":"Hacke","year":"1997","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0100|cit100","first-page":"181","article-title":"Potential contributors to bad functional outcome or death in European Cooperative Acute Stroke Study (ECASS)","volume":"6","author":"Kaste M for the ECASS Study Group","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/978-3-642-78061-5_10","article-title":"The European Cooperative Acute Stroke Study (ECASS)","volume-title":"Thrombolytic therapy in acute ischaemic stroke","author":"Kaste","year":"1993"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0102|cit102","unstructured":"Kaste M Mau J Bluhmki E Del Zoppo GJ Orgogozo J-M Overgaard K A post-hoc risk\/benefit assessment for mortality and handicap in 615 ECASS patients randomised and treated Upsala Journal of Medical Sciences 1997"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0103|cit103","first-page":"S20","article-title":"Risk\/benefit assessment for mortality and handicap among 615 patients randomised and treated in ECASS","volume":"5 Suppl 1","author":"Kaste","year":"1998","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0104|cit104","first-page":"288","article-title":"Risk\/benefit assessment for mortality and handicap in ECASS randomised and treated patients: a post-hoc analysis","volume":"29","author":"Kaste","year":"1998","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0105|cit105","first-page":"129","article-title":"Potential contributors for good vs bad functional outcome or death in European Cooperative Acute Stroke Study (ECASS)","volume":"6","author":"Kaste","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.STR.28.5.957","article-title":"Hemorrhagic transformation in acute ischaemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study","volume":"28","author":"Larrue","year":"1997","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0107|cit107","first-page":"181","article-title":"Predictors of hemorrhagic transformation in the ECASS trial","volume":"6","author":"Larrue","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.STR.30.4.769","article-title":"Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator","volume":"30","author":"Manelfe","year":"1999","journal-title":"Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0109|cit109","first-page":"55","article-title":"Would first-day body temperature dynamics contribute independently to long-term handicap after acute ischemic stroke?","volume":"21","author":"Mau","year":"2006","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0111|cit110","first-page":"96","article-title":"First-day body temperature dynamics - a clinician's tool for monitoring penumbral tissue transformation and updating prognosis after ischemic stroke?","volume":"23","author":"Mau","year":"2007","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0110|cit111","first-page":"30","article-title":"A robust prognostic advantage with \"late\" rising body temperature profiles in the ECASS-I data base","volume":"1 Suppl 2","author":"Mau","year":"2006","journal-title":"International Journal of Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0112|cit112","first-page":"1","article-title":"A risk\/benefit assessment of 1.1 mg\/kg iv rt-PA in 615 acute stroke patients of ECASS","volume":"7","author":"Mau","year":"1997","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0113|cit113","first-page":"247","article-title":"Risk profile comparison in 615 patients randomised to either 1.1 mg\/kg intravenous rt-PA or placebo of ECASS 1","volume":"30","author":"Mau","year":"1999","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0114|cit114","first-page":"e189","article-title":"Beta-blockers with thrombolysis? Cautioning evidence from the ECASS-1 trial","volume":"35","author":"Mau","year":"2004","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/01.STR.30.3.502","article-title":"Delayed increase in infarct volume after cerebral ischaemia. Correlations with thrombolytic treatment and clinical outcome","volume":"30","author":"Pantano","year":"1999","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000015851","article-title":"The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification","volume":"8","author":"Steiner","year":"1998","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0117|cit117","first-page":"182","article-title":"Predictors of good outcome - ECASS trial","volume":"6","author":"The ECASS Trial","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1148\/radiology.205.2.9356611","article-title":"Acute stroke - usefulness of early CT findings before thrombolytic therapy","volume":"205","author":"Kummer","year":"1997","journal-title":"Radiology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0119|cit119","first-page":"13","article-title":"Letter to the editor","volume":"275","author":"Kummer","year":"1996","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0120|cit120","first-page":"129","article-title":"Causes of death in ECASS","volume":"6","author":"Willig","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0121|cit121","first-page":"272","article-title":"Heparin effects in the European Cooperative Acute Stroke Study","volume":"28","author":"Willig","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.1996.03530370021010","article-title":"Letter to the editor","volume":"275","author":"Wood","year":"1996","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.STR.0000189998.74892.24","article-title":"Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke","volume":"36","author":"Yong","year":"2005","journal-title":"Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0124|cit124","first-page":"38","article-title":"Effect of thrombolysis on relationship between blood pressure and stroke outcome","volume":"21","author":"Yong","year":"2006","journal-title":"Cerebrovascular Diseases"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000106981","article-title":"Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis","volume":"24","author":"Yong","year":"2007","journal-title":"Cerebrovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0126|cit126","first-page":"e218","article-title":"Comparison of blood pressure profiles between rt-PA and placebo in the ECASS-1 trial","volume":"35","author":"Yong","year":"2004","journal-title":"Stroke"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S1474-4422(09)70264-9","article-title":"Stroke treatment with alteplase given 3\u00b70-4\u00b75 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial","volume":"8","author":"Bluhmki","year":"2009","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0128|cit128","unstructured":"Boehringer Ingelheim Pharmaceuticals Rt-PA in the treatment of acute ischemic stroke www.clinicaltrials.gov\/ct2\/show\/NCT00153036?term=Rt-PA+in+the+treatment+of+acute+ischemic+stroke&rank=1"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jemermed.2009.08.004","article-title":"Intravenous tissue plasminogen activator for stroke: a review of the ECASS III results in relation to prior clinical trials","volume":"38","author":"Cronin","year":"2010","journal-title":"Journal of Emergency Medicine"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1747-4949.2009.00248.x","article-title":"The ECASS III results and the tPA paradox","volume":"4","author":"Davis","year":"2009","journal-title":"International Journal of Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1161\/STROKEAHA.108.544171","article-title":"4.5 Hours. The new time window for tissue plasminogen activator in stroke","volume":"40","author":"Davis","year":"2009","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/STROKEAHA.108.544163","article-title":"European Cooperative Acute Stroke Study III. Support for and questions about a truly emerging therapy","volume":"40","author":"Fisher","year":"2009","journal-title":"Stroke"},{"issue":"26","key":"10.1002\/14651858.CD000213.pub3-BIB0133|cit133","first-page":"2840","article-title":"Thrombolysis 3 to 4.5 hours after acute ischemic stroke (to the Editor)","volume":"359","author":"Fitzpatrick","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0137|cit134","first-page":"444","article-title":"A wider time window for regular i.v. lysis: towards the result of ECASS-3","volume":"3","author":"Hacke","year":"2008","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0134|cit135","first-page":"183","article-title":"European cooperative acute stroke study 3 (ECASS 3): study design and progress report","volume":"12 Suppl 2","author":"Hacke","year":"2005","journal-title":"European Journal of Neurology"},{"issue":"13","key":"10.1002\/14651858.CD000213.pub3-BIB0135|cit136","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"26","key":"10.1002\/14651858.CD000213.pub3-BIB0136|cit137","first-page":"2841","article-title":"Thrombolysis 3 to 4.5 hours after acute ischemic stroke (the authors' reply)","volume":"359","author":"Hacke","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/STROKEAHA.108.544189","article-title":"Intravenous thrombolysis for acute ischemic stroke. Time is prime","volume":"40","author":"Ingall","year":"2009","journal-title":"Stroke"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1161\/STROKEAHA.109.552398","article-title":"Treating patients with ischemic stroke with tissue plasminogen activator in the 3.5- to 4-hour window. Numbers support benefit but the message is to still go fast","volume":"40","author":"Kurth","year":"2009","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0140|cit140","first-page":"2","article-title":"Intravenous thrombolysis: results of the Italian Sits-Most Study, ECASS III Study and SITS-ISTR","volume":"26","author":"Lorenzano","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"13","key":"10.1002\/14651858.CD000213.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMe0806335","article-title":"Thrombolytic therapy for acute stroke - not a moment to lose","volume":"359","author":"Lyden","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"26","key":"10.1002\/14651858.CD000213.pub3-BIB0142|cit142","first-page":"2840","article-title":"Thrombolysis 3 to 4.5 hours after acute ischemic stroke (to the Editor)","volume":"359","author":"Morris","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/STROKEAHA.108.543561","article-title":"Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window. Joint outcome table analysis of the ECASS 3 Trial","volume":"40","author":"Saver","year":"2009","journal-title":"Stroke"},{"issue":"26","key":"10.1002\/14651858.CD000213.pub3-BIB0144|cit144","first-page":"2840","article-title":"Thrombolysis 3 to 4.5 hours after acute ischemic stroke (to the Editor)","volume":"359","author":"Schwamm","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"26","key":"10.1002\/14651858.CD000213.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1056\/NEJMc082179","article-title":"Thrombolysis 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Torbey","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"49","key":"10.1002\/14651858.CD000213.pub3-BIB0146|cit146","first-page":"2653","article-title":"Treatment of acute ischaemic stroke with intravenous thrombolysis: extension of the time window should not delay initiation of treatment","volume":"152","author":"Uyttenbogaart","year":"2008","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0147|cit147","first-page":"e107","article-title":"Relation of blood pressure with outcomes after intravenous thrombolysis in the Third European Cooperative Acute Stroke Study","volume":"40","author":"Wahlgren","year":"2009","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/STROKEAHA.107.492330","article-title":"Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial","volume":"39","author":"Yong","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(05)74844-3","article-title":"Letter to the editor","volume":"353","author":"Barer","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.STR.31.7.1545","article-title":"Reperfusion and metabolic recovery of brain tissue and clinical outcome after ischaemic stroke and thrombolytic therapy","volume":"31","author":"Berrouschot","year":"2000","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0151|cit151","first-page":"95","article-title":"Reperfusion after focal cerebral ischaemia does not increase the rate and severity of secondary haemorrhage","volume":"9","author":"Berrouschot","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0152|cit152","first-page":"267","article-title":"Thrombolysis with rt-PA: ASPECT study","volume":"30","author":"Berrouschot","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1161\/STROKEAHA.108.535278","article-title":"The hidden burden of glucose pathway in acute stroke remains hidden","volume":"40","author":"Brainin","year":"2009","journal-title":"Stroke"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD000213.pub3-BIB0156|cit154","first-page":"5","article-title":"Assessment of ischemic damage on early CT with and without the use of a quantitative score","volume":"17","author":"Dzialowski","year":"2004","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0157|cit155","first-page":"636","article-title":"Extent of ischemic edema on CT before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II","volume":"37","author":"Dzialowski","year":"2006","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0158|cit156","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/01.STR.0000206215.62441.56","article-title":"Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II","volume":"37","author":"Dzialowski","year":"2006","journal-title":"Stroke"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213.pub3-BIB0154|cit157","first-page":"9","article-title":"Fibrinolytic therapy for acute stroke: the Spanish experience","volume":"9","author":"D\u00e1valos A on behalf of the ECASS II Spanish Group","year":"1999","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0155|cit158","first-page":"33","article-title":"Type of acute stroke care, stroke outcome and safety parameters in the ECASS II trial: the Spanish experience","volume":"9","author":"D\u00e1valos","year":"1999","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0159|cit159","first-page":"128","article-title":"Final results of the second European-Australasian Acute Stroke Study of intravenous alteplase in acute ischaemic stroke (ECASS II)","volume":"9","author":"Fieschi","year":"1999","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0160|cit160","first-page":"14","article-title":"Natural history of ischaemic stroke in ECASS I and ECASS II placebo cohorts","volume":"9","author":"Fiorelli","year":"1999","journal-title":"Cerebrovascular Diseases"},{"issue":"9146","key":"10.1002\/14651858.CD000213.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(98)00005-1","article-title":"ECASS II: Intravenous alteplase in acute ischaemic stroke","volume":"353","author":"Ford","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0165|cit162","first-page":"S9","article-title":"The results of the European Co-operative Stroke Study II (ECASS II), a placebo-controlled, randomized study of thrombolytic therapy","volume":"5 Suppl 3","author":"Hacke","year":"1998","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0162|cit163","unstructured":"Hacke W for the ECASS II Study Group Thrombolysis in acute ischaemic stroke: ECASS II The Challenge of Stroke, Lancet Conference; 1999 Oct 15-16; Montreal 1999"},{"issue":"9146","key":"10.1002\/14651858.CD000213.pub3-BIB0163|cit164","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(05)74842-X","article-title":"Authors' reply","volume":"353","author":"Hacke","year":"1999","journal-title":"Lancet"},{"issue":"9136","key":"10.1002\/14651858.CD000213.pub3-BIB0164|cit165","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet"},{"issue":"9146","key":"10.1002\/14651858.CD000213.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(05)74843-1","article-title":"Letter to the editor","volume":"353","author":"Jenkinson","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0167|cit167","first-page":"278","article-title":"Risk factors for haemorrhagic transformation in ECASS II","volume":"31","author":"Larrue","year":"2000","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.STR.32.2.438","article-title":"Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)","volume":"32","author":"Larrue","year":"2001","journal-title":"Stroke"},{"issue":"9146","key":"10.1002\/14651858.CD000213.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(05)74846-7","article-title":"Letter to the editor","volume":"353","author":"Lees","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/CIRCOUTCOMES.111.964064","article-title":"Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke","volume":"5","author":"Mess\u00e9","year":"2012","journal-title":"Circulation. Cardiovascular Quality and Outcomes"},{"issue":"9146","key":"10.1002\/14651858.CD000213.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(05)74845-5","article-title":"Letter to the editor","volume":"353","author":"Raha","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0172|cit172","first-page":"576","article-title":"Rankin shift analysis of the NINDS and ECASS-II trials","volume":"38","author":"Savitz","year":"2007","journal-title":"Stroke"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1161\/STROKEAHA.107.489351","article-title":"Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials","volume":"38","author":"Savitz","year":"2007","journal-title":"Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0174|cit174","first-page":"82","article-title":"European-Australian cooperative acute stroke study II (ECASS II) - interim demographics and baseline characteristics","volume":"8","author":"Schaefer","year":"1998","journal-title":"Cerebrovascular Diseases"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000047608","article-title":"Bootstrap statistics of ECASS II data: Just another post hoc analysis of a negative stroke trial?","volume":"11","author":"Stingele","year":"2001","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000068510","article-title":"Acute stroke trials: the problems of local investigators?","volume":"49","author":"Toni","year":"2003","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0177|cit177","first-page":"301","article-title":"Baseline CT findings and the response of thrombolytic treatment in acute ischemic stroke","volume":"221 Suppl","author":"Kummer","year":"2001","journal-title":"Radiology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0178|cit178","first-page":"275","article-title":"The effect of early and late brain tissue reperfusion on infarct volume","volume":"31","author":"Kummer","year":"2000","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/STROKEAHA.107.492330","article-title":"Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial","volume":"39","author":"Yong","year":"2008","journal-title":"Stroke"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/STROKEAHA.108.514307","article-title":"Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II Trial","volume":"39","author":"Yong","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0181|cit181","first-page":"40","article-title":"Characteristics of blood pressure profiles and their prognostic value of stroke outcome","volume":"1 Suppl 1","author":"Yong","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0182|cit182","first-page":"34","article-title":"Review of characteristics of blood pressure profiles and long-term outcome in the ECASS-II database","volume":"1 Suppl 2","author":"Yong","year":"2006","journal-title":"International Journal of Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0183|cit183","first-page":"23","article-title":"Prognostic value of blood pressure profiles on cerebral hemorrhages in rt-PA treated patients","volume":"23","author":"Young","year":"2007","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD000213.pub3-BIB0184|cit184","first-page":"4","article-title":"Dual target (mismatch and vessel obstruction) at baseline MRI does not improve stroke patient selection for thrombolysis 3-6H","volume":"27","author":"Brekenfeld","year":"2009","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD000213.pub3-BIB0185|cit185","first-page":"22","article-title":"Hemorrhagic transformation in the Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET) is predicted by post-treatment blood pressure control and infarct volume","volume":"27","author":"Butcher","year":"2009","journal-title":"Cerebrovascular Diseases"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0186|cit186","first-page":"e152","article-title":"Post-treatment blood pressure control predicts thrombolysis related hemorrhagic transformation","volume":"40","author":"Butcher","year":"2009","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/STROKEAHA.109.563767","article-title":"Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation","volume":"41","author":"Butcher","year":"2010","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0188|cit188","unstructured":"Butcher K Davis S EPITHET protocol [personal communication] email to JM Wardlaw"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/STROKEAHA.107.490524","article-title":"Rapid assessment of perfusion-diffusion mismatch","volume":"39","author":"Butcher","year":"2008","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0190|cit190","first-page":"A1","article-title":"Reperfusion outweighs PWI-DWI mismatch in determining acute stroke outcome","volume":"35","author":"Butcher","year":"2005","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0196|cit191","unstructured":"Butcher KS Echoplanar imaging thrombolysis evaluation trial: EPITHET Proceedings of the 28th International Stroke Conference. February 13-15 2003; Phoenix, Arizona, USA 2003"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0197|cit192","unstructured":"Butcher KS Echoplanar imaging thrombolysis evaluation trial: EPITHET Proceedings of the International Stroke Conference 2005. Ongoing Clinical Trials Abstracts. 2 February 2005; New Orleans, Louisiana, USA 2005"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0191|cit193","first-page":"e198","article-title":"Multiple definitions of PWI-DWI mismatch reliably predict infarct growth","volume":"35","author":"Butcher","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0192|cit194","first-page":"259","article-title":"The frequency of perfusion-diffusion mismatch decreases with objective definition","volume":"35","author":"Butcher","year":"2004","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0193|cit195","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/01.STR.0000166181.86928.8b","article-title":"Refining the perfusion-diffusion mismatch hypothesis","volume":"36","author":"Butcher","year":"2005","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0194|cit196","first-page":"71","article-title":"MRI ASPECTS (Alberta Stroke Program Early CT Scores) predict perfusion-diffusion mismatch","volume":"19","author":"Butcher","year":"2005","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0195|cit197","first-page":"332","article-title":"Reperfusion is more important than PWI-DWI mismatch definition in determining tissue fate","volume":"12","author":"Butcher","year":"2005","journal-title":"Journal of Clinical Neuroscience"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0198|cit198","first-page":"7","article-title":"Prediction of haemorrhagic transformation after stroke thrombolysis: very low cerebral blood volume (VLCBV) outperforms DWI\/ADC lesion volume","volume":"4","author":"Campbell","year":"2009","journal-title":"International Journal of Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0199|cit199","first-page":"19","article-title":"Diffusion lesion reversal in acute ischemic stroke is uncommon in the 3-6hr treatment window","volume":"5","author":"Campbell","year":"2010","journal-title":"International Journal of Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0200|cit200","first-page":"Abst. 95","article-title":"Regional very low cerebral blood volume with subsequent local reperfusion predicts hemorrhagic transformation in acute ischemic stroke","volume":"43","author":"Campbell","year":"2012","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0201|cit201","first-page":"e246","article-title":"Very low cerebral blood volume predicts hemorrhagic transformation better than diffusion lesion volume in acute ischemic stroke","volume":"41","author":"Campbell","year":"2010","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/STROKEAHA.109.562116","article-title":"Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke","volume":"41","author":"Campbell","year":"2010","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0203|cit203","first-page":"3","article-title":"Major infarct growth beyond 6 hours is associated with collateral circulation failure","volume":"29","author":"Campbell","year":"2010","journal-title":"Cerebrovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1159\/000311080","article-title":"Visual assessment of perfusion-diffusion mismatch is inadequate to select patients for thrombolysis","volume":"29","author":"Campbell","year":"2010","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0205|cit205","first-page":"12","article-title":"Insights into the relationship of perfusion-diffusion mismatch and leptomeningeal collateral quality - simultaneous assessment through novel visualization of perfusion imaging","volume":"7","author":"Campbell","year":"2012","journal-title":"International Journal of Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000331467","article-title":"Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation","volume":"32","author":"Campbell","year":"2011","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0207|cit207","first-page":"e71","article-title":"The acute diffusion lesion reliably represents infarct core: clinically relevant reversibility is rare","volume":"42","author":"Campbell","year":"2011","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0208|cit208","first-page":"351","article-title":"Sodium MRI in acute stroke","volume":"12","author":"Chalk","year":"2005","journal-title":"Journal of Clinical Neuroscience"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1212\/WNL.0b013e3181f39ab6","article-title":"Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch","volume":"75","author":"Chemmanam","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0210|cit210","first-page":"e118","article-title":"High Tmax values on perfusion MRI often reflect low CBV - a pathophysiological link between the malignant perfusion profile and poor outcome?","volume":"42","author":"Christensen","year":"2011","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0211|cit211","first-page":"e297","article-title":"Optimal perfusion thresholds for prediction of tissue destined for infarction in the combined EPITHET and DEFUSE dataset","volume":"41","author":"Christensen","year":"2010","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0212|cit212","first-page":"33","article-title":"Optimal mismatch definitions for detecting treatment response in acute stroke","volume":"25","author":"Christensen","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0213|cit213","first-page":"e162","article-title":"Optimising MR criteria for penumbral selection trials","volume":"40","author":"Christensen","year":"2009","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0214|cit214","first-page":"e203","article-title":"Testing the mismatch hypothesis in the randomized EPITHET data Set: the effect of treatment, mismatch and their interaction on infarct growth","volume":"41","author":"Christensen","year":"2010","journal-title":"Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0215|cit215","first-page":"A74","article-title":"Optimizing mismatch definitions in acute stroke MRI - an EPITHET post hoc study","volume":"38","author":"Christensen","year":"2008","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0216|cit216","unstructured":"Davies S Davis SM Donnan GA Parsons M Butcher K Tress B Thrombolysis beyond 3 hours: The EPITHET trial Proceedings of the 7th International Symposium on Thrombolysis and Acute Stroke Therapy. 27-28 May 2002; Lyon, France 2002 50"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0218|cit217","first-page":"e177","article-title":"Clinical MRI trials: EPITHET\/DEFUSE\/DIAS\/MR RESCUE","volume":"35","author":"Davis","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0219|cit218","unstructured":"Davis S The use of MRI in the selection of thrombolytic therapy for stroke Proceedings of the 17th International Congress on Fibrinolysis and Proteolysis. 21-25 March 2004; Melbourne, Australia 2004 57"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0217|cit219","unstructured":"Davis S Donnan G Echoplanar Imaging Thrombolysis Evaluation Trial www.strokecenter.org"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0220|cit220","unstructured":"Davis SM Donnan G Echoplanar imaging thrombolysis evaluation trial (EPITHET) www.clinicaltrials.gov\/ct2\/show\/NCT00238537"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0223|cit221","unstructured":"Davis SM Donnan GA EchoPlanar Imaging Thrombolysis Evaluation Trial Powerpoint presentation"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0224|cit222","unstructured":"Davis SM Donnan GA Echoplanar Imaging Thrombolysis Evaluation Trial: EPITHET Proceedings of the International Stroke Conference 2006. Ongoing Clinical Trials Abstracts. 16 February 2006; Kissimmee, Florida, USA 2006"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0221|cit223","unstructured":"Davis SM Donnan GA De Silva DA Butcher KS Parsons M Levi C Results of EPITHET: Effects of tPA beyond 3 hours on infarct growth, reperfusion and clinical outcomes Proceedings of the International Stroke Conference 2008. 20-22 February 2008; New Orleans, USA 2008"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0222|cit224","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1474-4422(08)70044-9","article-title":"Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial","volume":"7","author":"Davis","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0225|cit225","unstructured":"De Silva D Data query for EPITHET [personal communication] Email to JM Wardlaw"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/STROKEAHA.109.562827","article-title":"The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET)","volume":"41","author":"Silva","year":"2010","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jocn.2007.07.071","article-title":"The incidence and degree of recanalization depends on site of arterial occlusion in acute ischemic stroke","volume":"15","author":"Silva","year":"2008","journal-title":"Journal of Clinical Neuroscience"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0228|cit228","first-page":"267","article-title":"Spontaneous and TPA-induced recanalization and reperfusion in the echoplanar imaging thrombolytic evaluation trial (EPITHET)","volume":"3","author":"Silva","year":"2008","journal-title":"International Journal of Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0229|cit229","first-page":"e207","article-title":"Does presence of arterial obstruction influence the treatment effect of intravenous tPA over placebo in the 3-6 hour time window?","volume":"41","author":"Silva","year":"2010","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0230|cit230","first-page":"7","article-title":"The impact of diabetes and admission blood glucose on outcomes in the Echoplanar Imaging Thrombolytic Evaluation Trial (Epithet)","volume":"25","author":"Silva","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000255969","article-title":"Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial","volume":"29","author":"Silva","year":"2010","journal-title":"Cerebrovascular Diseases"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1161\/STROKEAHA.108.543595","article-title":"Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET)","volume":"40","author":"Silva","year":"2009","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0233|cit233","first-page":"21","article-title":"Impact of baseline arterial obstruction site and degree on outcomes in the echoplanar imaging thrombolytic evaluation trial (EPITHET)","volume":"3","author":"Silva","year":"2008","journal-title":"International Journal of Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0234|cit234","first-page":"e208","article-title":"Large and severe baseline PWI volumes predict poor response to intravenous tPA vs. placebo in the pooled DEFUSE-EPITHET database","volume":"41","author":"Silva","year":"2010","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0235|cit235","unstructured":"EPITHET investigators Echoplanar imaging thrombolysis evaluation trial: EPITHET Proceedings of the 27th International Stroke Conference. Feb 7-9 2002; San Antonio, USA 2002 CTP330"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jocn.2007.07.045","article-title":"Expediting MRI-based proof of concept stroke trials using an earlier primary endpoint","volume":"15","author":"Ebinger","year":"2008","journal-title":"Journal of Clinical Neuroscience"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/STROKEAHA.108.532622","article-title":"Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point","volume":"40","author":"Ebinger","year":"2009","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0238|cit238","first-page":"34","article-title":"Expediting MRI-based proof of concept stroke trials using an earlier primary endpoint","volume":"25","author":"Ebinger","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0240|cit239","first-page":"17","article-title":"Clinical-diffusion mismatch and benefit from thrombolysis 3-6 hours after acute stroke","volume":"3","author":"Ebinger","year":"2008","journal-title":"International Journal of Stroke"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0239|cit240","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/STROKEAHA.109.548073","article-title":"Clinical-diffusion mismatch and benefit from thrombolysis 3 to 6 hours after acute stroke","volume":"40","author":"Ebinger","year":"2009","journal-title":"Stroke"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.clinph.2006.06.718","article-title":"Rapid EEG changes indicate reperfusion after tissue plasminogen activator injection in acute ischaemic stroke","volume":"117","author":"Finnigan","year":"2006","journal-title":"Clinical Neurophysiology"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0242|cit242","first-page":"e295","article-title":"DEFUSE and EPITHET: two different studies with one consistent message","volume":"41","author":"Lansberg","year":"2010","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/STROKEAHA.110.609008","article-title":"RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study","volume":"42","author":"Lansberg","year":"2011","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0245|cit244","first-page":"13","article-title":"Effect of reperfusion in the pooled DEFUSE-EPITHET database","volume":"5","author":"Lee","year":"2010","journal-title":"International Journal of Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0244|cit245","first-page":"95","article-title":"Poor outcome in malignant profile patients is strongly associated with reperfusion and parenchymal hematoma","volume":"5","author":"Lee","year":"2010","journal-title":"International Journal of Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0246|cit246","first-page":"e66","article-title":"The combination of reperfusion and recanalization predicts favorable outcome better than reperfusion or recanalization alone in target mismatch patients","volume":"42","author":"Lee","year":"2011","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0247|cit247","first-page":"e258","article-title":"Validation of the malignant profile in the DEFUSE-EPITHET pooled database","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0248|cit248","first-page":"e207","article-title":"Optimal definition of the malignant profile in the DEFUSE-EPITHET pooled database","volume":"41","author":"Mlynash","year":"2010","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/STROKEAHA.110.601609","article-title":"Refining the definition of the malignant profile. Insights from the DEFUSE-EPITHET pooled data set","volume":"42","author":"Mlynash","year":"2011","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/STROKEAHA.110.580464","article-title":"EPITHET. Positive result after reanalysis using baseline diffusion-weighted imaging\/perfusion-weighted imaging co-registration","volume":"42","author":"Nagakane","year":"2011","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/STROKEAHA.111.643932","article-title":"Moving beyond a single perfusion threshold to define penumbra: a novel probabilistic mismatch definition","volume":"43","author":"Nagakane","year":"2012","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0252|cit252","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/STROKEAHA.112.668301","article-title":"The effects of alteplase 3 to 6 hours after stroke in the EPITHET-DEFUSE combined dataset: post hoc case-control study","volume":"44","author":"Ogata","year":"2013","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0253|cit253","first-page":"36","article-title":"A topographic study of the evolution of MR mismatch patterns and clinical relevance","volume":"5","author":"Ogata","year":"2010","journal-title":"Journal of Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1161\/STROKEAHA.110.609016","article-title":"A topographic study of the evolution of the MR DWI\/PWI mismatch pattern and its clinical impact: a study by the EPITHET and DEFUSE Investigators","volume":"42","author":"Ogata","year":"2011","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0256|cit255","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/jcbfm.2010.3","article-title":"Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis","volume":"30","author":"Parsons","year":"2010","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0255|cit256","first-page":"14","article-title":"Leukoaraiosis is not an independent risk factor for parenchymal hemorrhage after thrombolysis","volume":"20","author":"P\u00e9rez de la Ossa","year":"2010","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0257|cit257","first-page":"Abst 61","article-title":"Reperfusion beyond 4.5 hours reduces infarct growth and improves clinical outcome","volume":"43","author":"Ricanco","year":"2012","journal-title":"Stroke"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S1474-4422(08)70123-6","article-title":"EPITHET -- Where next?","volume":"7","author":"Sandercock","year":"2008","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1474-4422(08)70045-0","article-title":"EPITHET: failed chance or new hope?","volume":"7","author":"Schellinger","year":"2008","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0260|cit260","first-page":"e295","article-title":"Is reduced CBV a reliable surrogate marker for infarct core and can it be used to identify mismatch?","volume":"41","author":"Straka","year":"2010","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/STROKEAHA.108.525683","article-title":"Use of MRI to estimate the therapeutic window in acute stroke. Is perfusion-weighted imaging\/diffusion-weighted imaging mismatch an EPITHET for salvageable ischemic brain tissue?","volume":"40","author":"Toth","year":"2009","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0262|cit262","first-page":"7","article-title":"Atrial fibrillation is associated with increased infarct size, hemorrhagic transformation and worse outcome in patients with ischaemic stroke","volume":"4","author":"Tu","year":"2009","journal-title":"International Journal of Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0263|cit263","first-page":"29","article-title":"More severe hypoperfusion leads to greater infarct growth and worse stroke outcome in atrial fibrillation","volume":"6","author":"Tu","year":"2011","journal-title":"International Journal of Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0264|cit264","first-page":"e337","article-title":"The effects of atrial fibrillation on infarct evolution and outcome","volume":"41","author":"Tu","year":"2010","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000316886","article-title":"Pathophysiological determinants of worse stroke outcome in atrial fibrillation","volume":"30","author":"Tu","year":"2010","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0266|cit266","first-page":"e119","article-title":"Worse stroke outcome in atrial fibrillation links to more severe hypoperfusion","volume":"42","author":"Tu","year":"2011","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/STROKEAHA.108.540641","article-title":"Surrogate outcomes. A cautionary note","volume":"40","author":"Wardlaw","year":"2009","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/STROKEAHA.111.635888","article-title":"The role of bolus delay and dispersion in predictor models for stroke","volume":"43","author":"Willats","year":"2012","journal-title":"Stroke"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.STR.24.7.1000","article-title":"Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke","volume":"24","author":"Haley","year":"1993","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0270|cit270","first-page":"203","article-title":"Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke","volume":"42 Suppl 3","author":"Haley","year":"1992","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(13)70149-2","article-title":"Thrombolysis with alteplase after stroke: extending outcomes","volume":"12","author":"Anderson","year":"2013","journal-title":"Lancet Neurology"},{"issue":"9843","key":"10.1002\/14651858.CD000213.pub3-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0140-6736(12)61411-1","article-title":"Department of Error (erratum)","volume":"380","author":"Anonymous","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0273|cit273","unstructured":"Broom A Broom N Stevens C Stoneman T Worsfold L Pay G The South West Stroke Research Network PCPI Newsletter The South West Stroke Research Network PCPI Newsletter 2012"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0274|cit274","unstructured":"Carpenter T Wardlaw JM Sandercock PAG Lindley RI Murray V Peeters A The Third International Stroke Trial (IST-3) perfusion and angiography study: current progress and participation Proceedings of the 19th European Stroke Conference 2010. 25-28 May 2010; Barcelona, Spain 2010"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0275|cit275","unstructured":"Chang K-C Thrombolysis for acute ischaemic stroke: the Third International Stroke Trial (IST-3) Proceedings of the 2003 Annual Meeting of Taiwan Stroke Society; 2003 Mar 22-23; Taiwan Taiwan Stroke Society 2003 104"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0276|cit276","first-page":"228","article-title":"The Third International Stroke Trial: thrombolysis (IST-3) in Poland: are we recruiting the right patients?","volume":"43","author":"Czlonkowska","year":"2009","journal-title":"Neurologia i Neurochirurgia Polska"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0277|cit277","first-page":"400","article-title":"Third International Stroke Trial (IST-3): Intravenous thrombolysis in ischemic insult","volume":"30","author":"Diener","year":"2012","journal-title":"Arzneimitteltherapie"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1747-4949.2012.00938.x","article-title":"IST-3: a major contribution to thrombolysis research","volume":"7","author":"Donnan","year":"2012","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0279|cit279","first-page":"61","article-title":"The third international stroke trial (IST-3) of intravenous thrombolysis with rt-PA: Baseline imaging features among 3035 patients randomised","volume":"7","author":"Farrall","year":"2012","journal-title":"International Journal of Stroke"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0281|cit280","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1742-6723.2012.01605.x","article-title":"Believing is seeing: Stroke thrombolysis remains unproven after the third international stroke trial (IST-3)","volume":"24","author":"Fatovich","year":"2012","journal-title":"Emergency Medicine Australasia"},{"issue":"9847","key":"10.1002\/14651858.CD000213.pub3-BIB0280|cit281","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(12)61591-8","article-title":"Thrombolysis in acute ischaemic stroke","volume":"380","author":"Fatovich","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1747-4949.2012.00939.x","article-title":"IST-3: no pragmatic answers","volume":"7","author":"Furlan","year":"2012","journal-title":"International Journal of Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0283|cit283","first-page":"480","article-title":"Thrombolysis for acute ischaemic stroke: the Third International Stroke Trial (IST-3)","volume":"9","author":"Hankey","year":"2002","journal-title":"Journal of Clinical Neuroscience"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1742-6723.2012.01604.x","article-title":"How is more negative evidence being used to support claims of benefit: The curious case of the third international stroke trial (IST-3)","volume":"24","author":"Hoffman","year":"2012","journal-title":"Emergency Medicine Australasia"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0285|cit285","unstructured":"Hughes S IST-3: tPA benefits sustained out to 18 months www.medscape.com 2013 Article No. 806690"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S1474-4422(13)70130-3","article-title":"Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial","volume":"12","author":"IST-3 Collaborative Group","year":"2013","journal-title":"Lancet Neurology"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S1474-4422(13)70130-3","article-title":"Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial","volume":"12","author":"IST-3 Collaborative Group","year":"2013","journal-title":"Lancet Neurology"},{"issue":"9834","key":"10.1002\/14651858.CD000213.pub3-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","article-title":"The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial","volume":"379","author":"IST-3 Collaborative Group","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0289|cit289","doi-asserted-by":"crossref","first-page":"416","DOI":"10.12968\/bjon.2003.12.7.11262","article-title":"Thrombolysis for acute ischaemic stroke: core nursing requirements","volume":"12","author":"Innes","year":"2003","journal-title":"British Journal of Nursing"},{"issue":"5-6","key":"10.1002\/14651858.CD000213.pub3-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000091541","article-title":"Impact of stroke syndrome and stroke severity on the process of consent in the Third International Stroke Trial","volume":"21","author":"Kane","year":"2006","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0291|cit291","first-page":"76","article-title":"Consent for thrombolysis for acute ischaemic stroke","volume":"19","author":"Kane","year":"2005","journal-title":"Cerebrovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0302|cit292","first-page":"e200","article-title":"The Third International Stroke Trial (IST-3)","volume":"35","author":"Kane","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0292|cit293","unstructured":"Kane I Sandercock P Lindley R on behalf of the IST-3 Collaborative Group The Third International Stroke Conference www.esc-brussels.org\/esc_ongoing_trials.asp"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0293|cit294","unstructured":"Kane I Sandercock P Lindley R Gubitz G Phillips S IST-3 Collaborative Group The MRC Third International Stroke Trial (IST-3) asa.apprisor.com\/snap\/NET\/GT\/700.cfm"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0294|cit295","unstructured":"Kane I Sandercock P Lindley R IST-3 Collaborative Group Third International Stroke Trial www.abstractsonline.com\/arch\/RecordPrintView.aspx?Lookupkey=12345&RecordID=10978"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0295|cit296","unstructured":"Kane I Sandercock P Lindley R IST-3 Collaborative Group Third International Stroke Trial www.abstractsonline.com\/arch\/RecordPrintView.aspx?Lookupkey=12345&RecordID=16913"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD000213.pub3-BIB0296|cit297","first-page":"110","article-title":"The Third International Stroke Trial. Baseline characteristics of patients recruited in the expansion phase","volume":"17","author":"Kane","year":"2004","journal-title":"Cerebrovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0297|cit298","first-page":"e216","article-title":"The Third International Stroke Trial. Baseline characteristics of patients recruited in the expansion phase","volume":"35","author":"Kane","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0298|cit299","first-page":"i45","article-title":"The Third International Stroke Trial (IST-3). Thrombolysis for acute ischaemic stroke: characteristics of patients randomised in the expansion phase","volume":"34 Suppl 1","author":"Kane","year":"2005","journal-title":"Age and Ageing"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0299|cit300","first-page":"29","article-title":"The Third International Stroke Trial. Baseline characteristics of patients recruited in the expansion phase","volume":"19","author":"Kane","year":"2005","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0300|cit301","first-page":"450","article-title":"The Third International Stroke Trial: baseline characteristics of patients recruited in the expansion phase","volume":"36","author":"Kane","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0301|cit302","first-page":"295","article-title":"Third International Stroke Trial: characteristics of patients recruited in the start-up phase","volume":"35","author":"Kane","year":"2004","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0303|cit303","first-page":"1314","article-title":"The Third International Stroke Trial (IST-3). Thrombolysis for acute ischaemic stroke","volume":"76","author":"Kane","year":"2005","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0304|cit304","first-page":"797","article-title":"Third International Stroke Trial (IST-3). Thrombolysis for acute ischaemic stroke","volume":"75","author":"Kane","year":"2004","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0305|cit305","unstructured":"Kane I Wardlaw J Sandercock P Lewis S IST-3 Collaborative Group Baseline CT characteristics of the first 253 patients in the Third International Stroke Trial British Association of Stroke Physicians Annual Scientific Meeting; 2005 Jan 19; Newcastle upon Tyne 2005 4"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/1742-6723.12046","article-title":"Stroke thrombolysis and the third international stroke trial: Examining 'the totality of the evidence'","volume":"25","author":"Kleinig","year":"2013","journal-title":"Emergency Medicine Australasia"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0307|cit307","first-page":"35","article-title":"Correlation of stroke subtype in OCSP classification and early ischaemic changes on CT: an analysis based on the first 389 patients from the IST-3 Trial","volume":"21","author":"Kobayashi","year":"2006","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0308|cit308","first-page":"26","article-title":"Early ischaemic changes on CT and the OCSP classification: an analysis of the first 389 patients from the IST-3 Trial","volume":"13 Suppl 2","author":"Kobayashi","year":"2006","journal-title":"European Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0309|cit309","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/STROKEAHA.108.526772","article-title":"Oxfordshire Community Stroke Project clinical stroke syndrome and appearances of tissue and vascular lesions on pretreatment CT in hyperacute ischemic stroke among the first 510 patients in the Third International Stroke Trial (IST-3)","volume":"40","author":"Kobayashi","year":"2009","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0310|cit310","unstructured":"Lewis SC Sandercock PA Lindley RI Wardlaw JM Dennis MS The MRC Third International Stroke trial (IST-3) Proceedings of the 16th European Stroke Conference; 2007 May 29-June 1, Glasgow 2007"},{"issue":"9834","key":"10.1002\/14651858.CD000213.pub3-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/S0140-6736(12)60822-8","article-title":"rt-PA for ischaemic stroke: what will the next question be?","volume":"379","author":"Leys","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0312|cit312","first-page":"A84","article-title":"The Third International Stroke Trial (IST-3): thrombolysis for acute ischaemic stroke","volume":"37 Suppl 2","author":"Lindley","year":"2007","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0313|cit313","first-page":"A7","article-title":"Persisting hyperdense artery sign, aspects scores and risk of developing mass effect: analysis from the first 389 patients in IST-3","volume":"37 Suppl 1","author":"Lindley","year":"2008","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0319|cit314","unstructured":"Lindley RI The Third International Stroke Trial: thrombolysis for acute ischaemic stroke Proceedings of the American Stroke Association 28th International Stroke Conference; 2003 Feb 13-15; Arizona 2003 CTP22"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0314|cit315","doi-asserted-by":"crossref","first-page":"Abst.TMP23","DOI":"10.1161\/str.44.suppl_1.ATMP23","article-title":"Third international stroke trial (IST-3): subgroup effects of iv rt-PA < 6 hrs in acute ischemic stroke on symptomatic intracranial haemorrhage and outcome at 6 months","volume":"44","author":"Lindley","year":"2013","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0315|cit316","first-page":"135","article-title":"Hyperintense artery sign, atrial fibrillation and infarct subtype in the Third International Stroke Trial (IST-3)","volume":"3","author":"Lindley","year":"2008","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0316|cit317","first-page":"A96","article-title":"Hyperintense artery sign, atrial fibrillation and infarct subtype in the Third International Stroke Trial (IST-3)","volume":"38 Suppl 4","author":"Lindley","year":"2008","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0317|cit318","first-page":"A96","article-title":"Thrombolysis for stroke - what are the 'grey' areas of uncertainty and are they changing? Results from the Third International Stroke Trial IST-3","volume":"38 Suppl 4","author":"Lindley","year":"2008","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0318|cit319","unstructured":"Lindley RI Sandercock PAG Wardlaw JM Dennis MS The Third International Stroke Trial (IST-3) on behalf of the IST-3 Collaborative Group Proceedings of the 18th European Stroke Conference 2009. 26-29 May 2009; Stockholm, Sweden 2009"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0320|cit320","first-page":"A62","article-title":"The Third International Stroke Trial. Baseline characteristics of patients recruited","volume":"35 Suppl","author":"Lindley","year":"2005","journal-title":"Internal Medicine Journal"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0321|cit321","first-page":"A102","article-title":"The Third International Stroke Trial (IST-3): thrombolysis for acute ischaemic stroke","volume":"37","author":"Lueck","year":"2007","journal-title":"Internal Medicine Journal"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0322|cit322","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1161\/STROKEAHA.112.656876","article-title":"In anticipation of International Stroke Trial-3 (IST-3)","volume":"43","author":"Lyden","year":"2012","journal-title":"Stroke"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213.pub3-BIB0324|cit323","first-page":"237","article-title":"Combining CT angiography with non-contrast CT to predict infarct on follow up CT in acute ischaemic stroke. Substudy analysis of imaging from the third International Stroke Trial (IST-3)","volume":"35","author":"Mair","year":"2013","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213.pub3-BIB0323|cit324","first-page":"405","article-title":"Association of non-contrast CT and CT angiography with baseline clinical deficit and functional outcome. Substudy analysis of imaging from the third International Stroke Trial (IST-3)","volume":"35","author":"Mair","year":"2013","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0325|cit325","unstructured":"Murray V Norrving B Terent A Wester P Von Heijne A Isakson E Patient recruitment in IST-3, Sweden so far during the years 2003 and onwards Proceedings of the 18th European Stroke Conference 2009. 26-29 May 2009; Stockholm, Sweden 2009"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0326|cit326","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.annemergmed.2012.09.006","article-title":"Rt-PA and stroke: Does IST-3 make it all clear or muddy the waters?","volume":"60","author":"Radecki","year":"2012","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0327|cit327","unstructured":"Ricci S Celani MG Righetti E Cantisani AT Proceedings of the Conferenza Nazionale Sull'ictus Cerebrale; 2004 Mar 7-9; Firenze 2004 158"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0328|cit328","unstructured":"Ricci S Celani MG Righetti E Cantisani TA gruppo collaborative IST 3 Proceedings of the Conferenza Nazionale Sull'ictus Cerebrale; 2003 Mar 2-4; Firenze 2003 135"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0329|cit329","unstructured":"Ricci S Celani MG Righetti E Mazzoli T Thrombolysis for ischaemic stroke www.strokeforum.org\/Stroke2007\/Abstracts\/Freefiles\/ACTER_02.htm"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0330|cit330","first-page":"477","article-title":"Nurse-led telemedicine-directed hyper-acute stroke trial randomisation and management of post-thrombolysis anaphylaxis","volume":"33","author":"Roots","year":"2012","journal-title":"Cerebrovascular Diseases"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/jnnp.2007.126045","article-title":"Predicting outcome in hyper-acute stroke: validation of a prognostic model in the Third International Stroke Trial (IST3)","volume":"79","author":"IST","year":"2008","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213.pub3-BIB0332|cit332","first-page":"562","article-title":"Medical image management for multicentre trials. Experience from the Third International Stroke Trial (IST-3) with 6576 scans","volume":"35","author":"Sakka","year":"2013","journal-title":"Cerebrovascular Diseases"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0349|cit333","first-page":"6","article-title":"The Third International Stroke Trial (IST-3) of thrombolysis. Main results & implications for clinical practice","volume":"34","author":"Sandercock","year":"2012","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0350|cit334","first-page":"e25","article-title":"Update on the 3rd international stroke trial; effects of thrombolysis among 3035 stroke patients within 6 h of onset","volume":"10","author":"Sandercock","year":"2012","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0333|cit335","first-page":"s439","article-title":"Baseline CT characteristics of the first 317 patients in the MRC Third International Stroke Trial (IST-3)","volume":"238 Suppl 1","author":"Sandercock","year":"2005","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0341|cit336","unstructured":"Sandercock P Lindley R The Third International Stroke Trial (IST3) www.eurostroke.org"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0337|cit337","unstructured":"Sandercock P Lindley R Wardlaw J Protocol 06PRT\/1269: Third International Stroke Trial (IST-3) www.thelancet.com\/journals\/lancet\/misc\/protocol\/06PRT-1269"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0338|cit338","unstructured":"Sandercock P Lindley R Wardlaw J The Third International Stroke Trial Book of Abstracts of the UK Stroke Forum Conference; 2006 Dec 7-8; Harrogate 2006 59"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0339|cit339","unstructured":"Sandercock P Lindley R Wardlaw J Third International Stroke Trial (IST-3). A large-scale randomised trial of thrombolytic therapy for patients with acute ischaemic stroke ISRCTN ISRCTN25765518 Proceedings of the 19th European Stroke Conference 2010. 25-28 May 2010; Barcelona, Spain 2010"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0340|cit340","first-page":"5","article-title":"Thrombolysis for acute ischaemic stroke after ECASS 3 - what are remaining uncertainties?","volume":"4","author":"Sandercock","year":"2009","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0334|cit341","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1745-6215-12-252","article-title":"Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited","volume":"12","author":"Sandercock","year":"2011","journal-title":"Trials"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0335|cit342","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1745-6215-9-37","article-title":"The third international stroke trial (IST) of thrombolysis for acute ischaemic stroke","volume":"9","author":"Sandercock","year":"2008","journal-title":"Trials"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0336|cit343","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1747-4949.2012.00782.x","article-title":"Statistical analysis plan for the third International Stroke Trial (IST-3); part of a `thread` of reports of the trial","volume":"7","author":"Sandercock","year":"2012","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0342|cit344","unstructured":"Sandercock P Lindley R IST-3 Collaborative Group Third International Stroke Trial (IST-3) Proceedings of the British Association of Stroke Physicians Annual Conference; 2003 Jan 22; Stoke on Trent 2003 59"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0343|cit345","first-page":"444","article-title":"The Third International Stroke Trial (IST-3)","volume":"3","author":"Sandercock","year":"2008","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0344|cit346","unstructured":"Sandercock P Murray V Berge E IST 3 Collaborative Group Third International Stroke Trial (IST 3) Program and Abstract Book from the 12th Nordic Meeting on Cerebrovascular Diseases; 2003 Sep 17-20; Oslo 2003 26"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0345|cit347","first-page":"161","article-title":"Age and time to randomisation in the 2017 patients recruited to date in the third International Stroke Trial (IST-3)","volume":"29","author":"Sandercock","year":"2010","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0346|cit348","first-page":"194","article-title":"Time to randomisation following symptom onset in 2117 patients recruited to date in the third international stroke trial (IST-3)","volume":"5","author":"Sandercock","year":"2010","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0348|cit349","unstructured":"Sandercock P Wardlaw JM Lindley RI Third International Stroke Trial (IST-3). A large-scale randomised trial of thrombolytic therapy for patients with acute ischaemic stroke ISRCTN25765518 Proceedings of the 20th European Stroke Conference 2011. 24-27 May 2011; Hamburg, Germany 2011"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0347|cit350","first-page":"16","article-title":"The third international stroke trial (IST-3) main results part I: primary and secondary outcomes among 3035 patients randomised","volume":"33","author":"Sandercock","year":"2012","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0351|cit351","unstructured":"Sandercock PA Lindley R Wardlaw J Lewis S Dennis M The Third International Stroke Trial (IST-3) Proceedings of the 17th European Stroke Conference; 2008 May 13-16; Nice 2008 Abst 4"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0352|cit352","unstructured":"Sandercock PA Lindley RI Wardlaw J Third International Stroke Trial (IST-3). A large-scale randomised trial of thrombolytic therapy for patients with acute ischaemic stroke ISRCTN25765518 Proceedings of the International Stroke Conference 2011. 8-11 February 2011; Los Angeles, USA 2011"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0354|cit353","unstructured":"Sandercock PA Wardlaw J Lindley R Third International Stroke Trial (IST-3) Proceedings of the International Stroke Conference 2010. 24-26 February 2010; San Antonio Texas, USA 2010"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0353|cit354","first-page":"192","article-title":"Thrombolysis for stroke - what are the \"grey areas\" of uncertainty and are they changing? Results from the third international stroke trial (IST-3)","volume":"25","author":"Sandercock","year":"2008","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0355|cit355","doi-asserted-by":"crossref","first-page":"AWMP22","DOI":"10.1161\/str.44.suppl_1.AWMP22","article-title":"Third international stroke trial (IST-3): Effect of IV RT-PA < 6 hours in acute ischaemic stroke on living circumstances and health related quality of life at six months","volume":"44","author":"Sandercock","year":"2013","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0363|cit356","unstructured":"Sandercock PAG Imaging perfusion deficits and thrombolysis safety and efficacy in acute ischaemic stroke: the Third International Stroke Trial www.controlled-trials.com\/mrct\/trial\/1988897\/third+international+stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0361|cit357","unstructured":"Sandercock PAG Lindley RI IST3 stroke.ahajournals.org\/cgi\/content\/full\/34\/2\/e1"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213.pub3-BIB0360|cit358","first-page":"25","article-title":"Confounding factors in acute stroke trials: how do stroke severity, brain image appearances, BP and age vary with time to randomisation? IST-3 experience","volume":"5","author":"Sandercock","year":"2010","journal-title":"International Journal of Stroke"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213.pub3-BIB0356|cit359","first-page":"34","article-title":"The third international stroke trial (IST-3): benefits of iv thrombolysis on functional outcome and health-related quality of life (HRQoL) persist to 18 months after treatment","volume":"35","author":"Sandercock","year":"2013","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0359|cit360","first-page":"138","article-title":"Thrombolysis for stroke - what are the 'grey areas' of uncertainty and are they changing? Results from the IST-3","volume":"3","author":"Sandercock","year":"2008","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0357|cit361","unstructured":"Sandercock PAG Lindley RI Wardlaw JM Dennis MS Lewis SC on behalf of the IST-3 collaborative group The MRC Third International Stroke Trial (IST-3) Proceedings of the UK Stroke Forum Conference; 2007 Dec 4-6; Harrogate 2007 69"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0358|cit362","unstructured":"Sandercock PAG Lindley RI Wardlaw JM Dennis MS Lewis SC on behalf of the IST-3 collaborative group Thrombolysis for stroke - what are the \"grey areas\" of uncertainty and are they changing? Results from the Third International Stroke Trial (IST-3) Proceedings of the UK Stroke Forum Conference; 2007 Dec 4-6; Harrogate 2007 71 2"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0362|cit363","first-page":"6","article-title":"The third international stroke trial (IST-3) of intravenous rt-PA: Effect of age and time on treatment effect among 3035 patients randomized","volume":"7","author":"Sandercock","year":"2012","journal-title":"International Journal of Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0364|cit364","first-page":"33","article-title":"Persisting hyperdense artery sign, ASPECTS score and risk of developing mass effect: an analysis based on the first 389 patients from the IST-3 Trial","volume":"21","author":"Skowronska","year":"2006","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0365|cit365","doi-asserted-by":"crossref","first-page":"bcr0620080266","DOI":"10.1136\/bcr.06.2008.0266","article-title":"Haemorrhagic transformation of a recent silent cerebral infarct during thrombolytic stroke treatment","volume":"2008","author":"Slot","year":"2008","journal-title":"BMJ Case Reports"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0366|cit366","first-page":"136","article-title":"Baseline CT characteristics of the first 137 patients in the start-up phase of the MRC Third International Stroke Trial (IST-3)","volume":"77","author":"Venables","year":"2006","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0367|cit367","first-page":"S14","article-title":"The third international stroke trial (IST-3) of intravenous RT-PA: Effect of age and time among 3035 patients randomised","volume":"72","author":"Venables","year":"2012","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0368|cit368","doi-asserted-by":"crossref","first-page":"A10","DOI":"10.1161\/str.44.suppl_1.A10","article-title":"Perfusion imaging in patients randomised to rt-PA or control in the third international stroke trial (IST-3): baseline characteristics and association with outcome","volume":"44","author":"Wardlaw","year":"2013","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0369|cit369","unstructured":"Wardlaw J Sandercock P Carpenter T Von Kummer R Von Heijn A Murray V The Third International Stroke Trial (IST-3) a large randomised controlled trial of rt-PA in acute ischemic stroke: perfusion and angiography study: current progress and recruitment Proceedings of the International Stroke Conference 2011. 8-11 February 2011; Los Angeles, USA 2011"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0370|cit370","doi-asserted-by":"crossref","first-page":"A104","DOI":"10.1161\/str.44.suppl_1.A104","article-title":"The impact of ischemic and structural brain tissue changes on response to rt-PA: An analysis of imaging from 3035 patients in the third international stroke trial","volume":"44","author":"Wardlaw","year":"2013","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0371|cit371","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1747-4949.2007.00092.x","article-title":"The NeuroGrid stroke exemplar clinical trial protocol","volume":"2","author":"Wardlaw","year":"2007","journal-title":"International Journal of Stroke"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213.pub3-BIB0372|cit372","first-page":"111","article-title":"Does perfusion imaging lesion size or mismatch influence six month outcomes after rt-PA given up to six hours after acute ischaemic stroke? The third International Stroke Trial (IST-3)","volume":"35","author":"Wardlaw","year":"2013","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0373|cit373","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1747-4949.2006.00043.x","article-title":"Third International Stroke Trial","volume":"1","author":"Whiteley","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0374|cit374","unstructured":"Whiteley W Sandercock P Lewis S Wardlaw J Venables G The performance of UK centres in the Third International Stroke Trial Book of Abstracts from the UK Stroke Forum Conference; 2006 Dec 7-8; Harrogate, UK 2006 57 8"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0375|cit375","first-page":"488","article-title":"CT appearance at baseline in the MRC Third International Stroke Trial: relationship with time from stroke onset to scan and stroke severity","volume":"38","author":"Whiteley","year":"2007","journal-title":"Stroke"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213.pub3-BIB0376|cit376","first-page":"19","article-title":"IST-3 trial: impact of rt-PA on survival to 18 months post ischaemic stroke","volume":"35","author":"Whiteley","year":"2013","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213.pub3-BIB0377|cit377","first-page":"169","article-title":"Predictions of intracranial haemorrhage and the risks and benefits of rtPA in acute ischaemic stroke: an analysis of the IST-3 trial","volume":"35","author":"Whiteley","year":"2013","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0378|cit378","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-2007-1002675","article-title":"Clinical effects and basic studies of thrombolytic therapy on cerebral thrombosis","volume":"16","author":"Terashi","year":"1990","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0379|cit379","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/978-3-642-76439-4_20","article-title":"Thrombolytic therapy in embolic and thrombotic cerebral infarction: a cooperative study","volume-title":"Thrombolytic Therapy in Acute Ischemic Stroke","author":"Yamaguchi","year":"1991"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0380|cit380","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-642-78061-5_9","article-title":"Intravenous tissue plasminogen activator in acute thromboembolic stroke: A placebo-controlled, double-blind trial","volume-title":"Thrombolytic Therapy in Acute Ischemic Stroke II","author":"Yamaguchi","year":"1993"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0381|cit381","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000108714","article-title":"Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke","volume":"3","author":"Yamaguchi","year":"1993","journal-title":"Cerebrovascular Diseases"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0382|cit382","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.STR.0000227191.01792.e3","article-title":"Alteplase at 0.6 mg\/kg for acute ischemic stroke within 3 hours of onset. Japan Alteplase Clinical Trial (J-ACT)","volume":"37","author":"Yamaguchi","year":"2006","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0383|cit383","first-page":"21","article-title":"Intra observer concordance of the neuroradiologic reviewing committee in CT scan reviewing in MAST-E","volume":"6","author":"Besson","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"8949","key":"10.1002\/14651858.CD000213.pub3-BIB0384|cit384","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(95)90484-0","article-title":"Trials of streptokinase in severe acute ischaemic stroke","volume":"345","author":"Donnan","year":"1995","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0385|cit385","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/oxfordjournals.eurheartj.a015454","article-title":"TPA in acute stroke","volume":"18","author":"Hacke","year":"1997","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0386|cit386","first-page":"183","article-title":"Multicentre Acute Stroke Trial-Europe trial: predictors of good outcome","volume":"6","author":"Hommel","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0387|cit387","first-page":"182","article-title":"Multicentre Acute Stroke Trial-Europe trial: risk factors for the development of oedema, haemorrhage, bad neurological, bad functional outcome and death","volume":"6","author":"Hommel","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"8949","key":"10.1002\/14651858.CD000213.pub3-BIB0388|cit388","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(95)90484-0","article-title":"Trials of streptokinase in severe acute ischaemic stroke (authors' reply)","volume":"345","author":"Hommel","year":"1995","journal-title":"Lancet"},{"issue":"8941","key":"10.1002\/14651858.CD000213.pub3-BIB0389|cit389","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(95)91179-0","article-title":"Termination of trial of streptokinase in severe acute ischaemic stroke","volume":"345","author":"Hommel","year":"1994","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0390|cit390","first-page":"76","article-title":"Multicentre Acute Stroke Trial-Europe trial: predictors of good outcome","volume":"6","author":"Hommel","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0391|cit391","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.STR.30.7.1326","article-title":"Haemorrhagic transformation in acute ischaemic stroke. The MAST-E Study","volume":"30","author":"Jaillard","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0392|cit392","unstructured":"Jaillard AS Hommel M Predictive factors related to outcome at one year after IV thrombolysis\/the MAST-E study Abstracts from the 6th International Symposium on Acute Stroke and Thrombolytic Therapy; 2000 Nov 25-29; Hamilton Island (Australia) 2001"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0393|cit393","first-page":"79","article-title":"Predictive factors related to outcome at one year after intravenous thrombolysis: the MAST-E study","volume":"10","author":"Jaillard","year":"2000","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0394|cit394","first-page":"189","article-title":"Predictive value of early CT signs in MCA occlusion","volume":"5","author":"Moulin","year":"1995","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0395|cit395","first-page":"128","article-title":"Predictive factors for hemorrhagic transformations in MAST-E","volume":"6","author":"Moulin","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0396|cit396","first-page":"182","article-title":"Haemorrhagic transformations in MAST-E trial: predictive factors","volume":"6","author":"Moulin","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"8949","key":"10.1002\/14651858.CD000213.pub3-BIB0397|cit397","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(95)90484-0","article-title":"Trials of streptokinase in severe acute ischaemic stroke","volume":"345","author":"Shahar","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0398|cit398","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM199607183350301","article-title":"Thrombolytic therapy with streptokinase in acute ischaemic stroke","volume":"335","author":"The Multicentre Acute Stroke Trial - Europe Study Group","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0399|cit399","first-page":"129","article-title":"Long term effect of thrombolytic treatment in acute ischaemic stroke","volume":"6","author":"Aritzu","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0400|cit400","first-page":"190","article-title":"Prognostic value of haemorrhagic transformations in acute ischaemic stroke","volume":"6","author":"Aritzu","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"8998","key":"10.1002\/14651858.CD000213.pub3-BIB0401|cit401","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(96)90568-1","article-title":"Multicentre Acute Stroke Trial - Italy","volume":"347","author":"Barer","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0406|cit402","unstructured":"Candelise L The long term effects of acute treatment with streptokinase and\/or aspirin Book of Abstracts Proceedings of the 6th International Conference on Thrombolysis in Acute Ischaemic Stroke; 2000 Nov 25-29; Hamilton Island (Australia) 2001 3"},{"issue":"8998","key":"10.1002\/14651858.CD000213.pub3-BIB0402|cit403","first-page":"393","article-title":"Multicentre Acute Stroke Trial - Italy","volume":"347","author":"Candelise","year":"1996","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0403|cit404","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/01.STR.31.7.1785","article-title":"Extraparenchymal bleeding predicts an unfavorable outcome in patients with hemorrhagic transformation","volume":"31","author":"Candelise","year":"2000","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0404|cit405","first-page":"23","article-title":"Aspirin given within 6 hours reduces long term case fatality but not stroke related disability","volume":"6","author":"Candelise","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0405|cit406","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01995705","article-title":"Thrombolytic therapy. From myocardial to cerebral infarction","volume":"17","author":"Candelise","year":"1996","journal-title":"Italian Journal of Neurological Sciences"},{"issue":"8998","key":"10.1002\/14651858.CD000213.pub3-BIB0407|cit407","first-page":"392","article-title":"Multicentre Acute Stroke Trial - Italy","volume":"347","author":"Carolei","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0408|cit408","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000016026","article-title":"Negative interaction of aspirin and streptokinase in acute ischaemic stroke: further analysis of the Multicentre Acute Stroke Trial-Italy","volume":"10","author":"Ciccone","year":"2000","journal-title":"Cerebrovascular Diseases"},{"issue":"9131","key":"10.1002\/14651858.CD000213.pub3-BIB0409|cit409","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(05)60007-4","article-title":"Risk of aspirin use plus thrombolysis after acute ischaemic stroke: a further MAST-I analysis. MAST-I Collaborative Group. Multicentre Acute Stroke Trial--Italy","volume":"352","author":"Ciccone","year":"1998","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0410|cit410","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/01.STR.31.7.1785","article-title":"Extraparenchymal bleeding predicts an unfavorable outcome in patients with hemorrhagic transformation","volume":"31","author":"Fiorelli","year":"2000","journal-title":"Stroke"},{"issue":"8989","key":"10.1002\/14651858.CD000213.pub3-BIB0411|cit411","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(95)92043-9","article-title":"MAST-I: agreeing to disagree: Multicentre Acute Stroke Trial--Italy Group","volume":"346","author":"Horton","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0412|cit412","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/01.STR.28.2.302","article-title":"Reliability of hemorrhagic transformation diagnosis in acute ischemic stroke","volume":"28","author":"Motto","year":"1997","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0413|cit413","first-page":"129","article-title":"Aspirin in combination with thrombolysis increases the risk of early death but not of intracranial bleeding in patients with acute ischaemic stroke","volume":"6","author":"Motto","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0414|cit414","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.STR.30.4.761","article-title":"Haemorrhage after an acute ischaemic stroke","volume":"30","author":"Motto","year":"1999","journal-title":"Stroke"},{"issue":"8998","key":"10.1002\/14651858.CD000213.pub3-BIB0415|cit415","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(96)90568-1","article-title":"Multicentre Acute Stroke Trial--Italy","volume":"347","author":"Muir","year":"1996","journal-title":"Lancet"},{"issue":"8989","key":"10.1002\/14651858.CD000213.pub3-BIB0416|cit416","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(95)92049-8","article-title":"Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke","volume":"346","author":"Multicentre Acute Stroke Trial - Italy (MAST-I) Group","year":"1995","journal-title":"Lancet"},{"issue":"8998","key":"10.1002\/14651858.CD000213.pub3-BIB0417|cit417","first-page":"392","article-title":"Multicentre Acute Stroke Trial- -Italy","volume":"347","author":"Rothwell","year":"1996","journal-title":"Lancet"},{"issue":"8989","key":"10.1002\/14651858.CD000213.pub3-BIB0418|cit418","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(95)92044-7","article-title":"Thrombolytic therapy for acute ischaemic stroke: promising, perilous or unproven?","volume":"346","author":"Sandercock","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0419|cit419","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/978-4-431-68459-6_23","article-title":"Is thrombolysis useful for acute stroke patients? The experience of the MAST-I study","volume-title":"Thrombolytic Therapy in Acute Ischaemic Stroke III","author":"The MAST-I Collaborative Group","year":"1995"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0420|cit420","first-page":"183","article-title":"Predictors of good outcome in the MAST Italy trial","volume":"6","author":"The MAST-Italy Investigators","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0421|cit421","first-page":"181","article-title":"Risk factors in the MAST-Italy trial","volume":"6","author":"The MAST-Italy Investigators","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"8989","key":"10.1002\/14651858.CD000213.pub3-BIB0422|cit422","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0140-6736(95)92050-1","article-title":"Dissent: an alternative interpretation of MAST-I","volume":"346","author":"Tognoni","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0424|cit423","first-page":"2","article-title":"Thrombolysis in acute ischaemic stroke","volume":"1","author":"Wardlaw","year":"1996","journal-title":"Neurology Reviews International"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0423|cit424","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s004150050512","article-title":"The influence of baseline prognostic variables on outcome after thrombolysis: MAST-Italy Collaborative Group","volume":"246","author":"Wardlaw","year":"1999","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0425|cit425","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/4-431-28576-8_13","article-title":"MCA Embolism Local Fibrinolytic Intervention Trial (MELT) Japan","volume-title":"Minimally Invasive Neurosurgery and Multidisciplinary Neurotraumatology","author":"Ezura","year":"2006"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0426|cit426","unstructured":"MELT MCA Embolism Local Fibrinolytic Intervention Trial melt.umin.ac.jp\/en\/"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0427|cit427","first-page":"16","article-title":"CT in acute stroke: learning from MELT-JAPAN","volume":"1","author":"Mori","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0431|cit428","unstructured":"Ogawa MCA-Embolism Local fibrinolytic intervention Trial www.strokecenter.org\/trials\/TrialDetail.aspx?tid=589&printView=true"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0430|cit429","unstructured":"Ogawa A MCA-Embolism Local Fibrinolytic Intervention Trial www.strokecenter.org\/trials\/TrialDetail.aspx?tid=589"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD000213.pub3-BIB0428|cit430","first-page":"519","article-title":"MELT Japan (MCA - Embolism Local Fibrinolytic Intervention Trial Japan)","volume":"64","author":"Ogawa","year":"2006","journal-title":"Nippon Rinsho"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0429|cit431","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1161\/STROKEAHA.107.488551","article-title":"Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke. The Middle Cerebral Artery Embolism Local Fibrinolygic Intervention Trial (MELT) Japan","volume":"38","author":"Ogawa","year":"2007","journal-title":"Stroke"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0432|cit432","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/STROKEAHA.107.490417","article-title":"Intra-arterial fibrinolysis for acute ischemic stroke. The message of MELT","volume":"38","author":"Saver","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0433|cit433","first-page":"40","article-title":"Characteristics of blood pressure profiles and their prognostic value of stroke outcome","volume":"1 Suppl","author":"Yong","year":"2006","journal-title":"International Journal of Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0434|cit434","first-page":"I","article-title":"Intra-arterial urokinase infusion therapy in acute thromboembolic stroke","volume":"21","author":"Mori","year":"1990","journal-title":"Stroke"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0435|cit435","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/01.STR.19.7.802","article-title":"Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery","volume":"19","author":"Mori","year":"1988","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0436|cit436","first-page":"347","article-title":"Double-blind, placebo-controlled trial of recombinant tissue plasminogen activator (rt-PA) in acute carotid stroke","volume":"41","author":"Mori","year":"1991","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0437|cit437","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1212\/WNL.42.5.976","article-title":"Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke","volume":"42","author":"Mori","year":"1992","journal-title":"Neurology"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0438|cit438","first-page":"727","article-title":"A pilot study of streptokinase for acute cerebral infarction","volume":"88","author":"Morris","year":"1995","journal-title":"Quarterly Journal of Medicine"},{"issue":"Suppl 30","key":"10.1002\/14651858.CD000213.pub3-BIB0439|cit439","doi-asserted-by":"crossref","first-page":"4p","DOI":"10.1042\/cs086004Pb","article-title":"Streptokinase for the treatment of acute cerebral infarction: a placebo controlled pilot study","volume":"86","author":"Morris","year":"1994","journal-title":"Clinical Science"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0440|cit440","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/labmed\/27.5.296","article-title":"Heart treatment reduces damage from stroke","volume":"27","author":"Anonymous","year":"1996","journal-title":"Laboratory Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0441|cit441","first-page":"Abst.3916","article-title":"Rapidly improving stroke symptoms: relation to stroke volumes and discharge disposition","volume":"43","author":"Balucani","year":"2012","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0442|cit442","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01376517-199712000-00006","article-title":"Nursing management of acute complications following rt-PA in acute ischemic stroke","volume":"29","author":"Barch","year":"1997","journal-title":"Journal of Neuroscience Nursing"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0443|cit443","first-page":"e120","article-title":"Dramatic early improvement in the NINDS trial: better 90 day outcomes and no increased rates of intracranial hemorrhage","volume":"40","author":"Bonomo","year":"2009","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0444|cit444","first-page":"2828","article-title":"Apo E phenotype and the efficacy of intravenous t-PA in acute ischemic stroke","volume":"31","author":"Broderick","year":"2000","journal-title":"Stroke"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0445|cit445","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/01.STR.31.10.2335","article-title":"Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS t-PA Stroke Trial","volume":"31","author":"Broderick","year":"2000","journal-title":"Stroke"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0447|cit446","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archneur.1996.00550120117025","article-title":"Thrombolysis for stroke","volume":"53","author":"Brott","year":"1996","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0446|cit447","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1161\/01.STR.29.8.1504","article-title":"Hypertension and its treatment in the NINDS rt-PA stroke trial","volume":"29","author":"Brott","year":"1998","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0449|cit448","first-page":"320","article-title":"Predicting major neurological improvement with intravenous rt-PA treatment of stroke","volume":"34","author":"Brown","year":"2003","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0448|cit449","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.STR.0000105396.93273.72","article-title":"Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke","volume":"35","author":"Brown","year":"2004","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0450|cit450","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.59.5.669","article-title":"Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial","volume":"59","author":"Bruno","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0451|cit451","first-page":"693","article-title":"Percent change of neurological deficits in acute stroke: another useful outcome measure","volume":"39","author":"Bruno","year":"2008","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0452|cit452","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.09.002","article-title":"Percent change on the National Institutes of Health Stroke Scale: a useful acute stroke outcome measure","volume":"18","author":"Bruno","year":"2009","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0453|cit453","first-page":"494","article-title":"The change in National Institute of Health Stroke Scale score over time in the NINDS rtPA stroke study","volume":"36","author":"Burger","year":"2005","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0454|cit454","first-page":"e254","article-title":"Predictors of functional improvement after the first 3 months following ischemic stroke","volume":"40","author":"Cordina","year":"2009","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0455|cit455","first-page":"e214","article-title":"Does Aspirin failure increase the chances of recurrent stroke and\/or death among patients with ischemic stroke: a pooled analysis of two prospective trials","volume":"41","author":"Cordina","year":"2010","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0456|cit456","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1371\/journal.pmed.0050113","article-title":"A user`s guide to the NINDS rt-PA stroke trial database","volume":"5","author":"Dachs","year":"2008","journal-title":"PLos Medicine"},{"issue":"21","key":"10.1002\/14651858.CD000213.pub3-BIB0457|cit457","first-page":"1406","article-title":"Tissue plasminogen activator for acute ischaemic stroke (authors' reply)","volume":"334","author":"Zoppo","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0458|cit458","first-page":"448","article-title":"Importance of early ischemic CT changes using ASPECTS in NINDS rtPA stroke study","volume":"36","author":"Demchuk","year":"2005","journal-title":"Stroke"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0459|cit459","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/01.STR.0000181116.15426.58","article-title":"Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA stroke study","volume":"36","author":"Demchuk","year":"2005","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0460|cit460","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000139658","article-title":"Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study","volume":"26","author":"Demchuk","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0461|cit461","first-page":"521","article-title":"Predictors of slow recovery after acute ischemic stroke","volume":"38","author":"Elkins","year":"2007","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0462|cit462","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/WNL.50.4.883","article-title":"Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke","volume":"50","author":"Fagan","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0463|cit463","first-page":"52","article-title":"Prompt tissue plasminogen activator therapy increased quality of life and reduced costs in acute ischemic stroke","volume":"September\/Octob","author":"Fagan","year":"1998","journal-title":"ACP Journal Club"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0464|cit464","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.01.003","article-title":"Repeated-measures analysis of the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial","volume":"20","author":"Feng","year":"2011","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"18","key":"10.1002\/14651858.CD000213.pub3-BIB0465|cit465","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1001\/jama.287.18.2361","article-title":"Early ischemic changes on computed tomography in patients with acute stroke","volume":"287","author":"Fiorelli","year":"2002","journal-title":"JAMA"},{"issue":"20","key":"10.1002\/14651858.CD000213.pub3-BIB0466|cit466","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1212\/01.wnl.0000316196.63704.f5","article-title":"How important is surrogate consent for stroke research?","volume":"71","author":"Flaherty","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0467|cit467","first-page":"600","article-title":"How important is surrogate consent for stroke research?","volume":"39","author":"Flaherty","year":"2008","journal-title":"Stroke"},{"issue":"21","key":"10.1002\/14651858.CD000213.pub3-BIB0468|cit468","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199605233342114","article-title":"Tissue plasminogen activator for acute ischaemic stroke","volume":"334","author":"Freidman","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0469|cit469","unstructured":"Genentech Inc Activase for acute ischemic stroke. Clinical Review http:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/HowDrugsareDevelopedandApproved\/ApprovalApplications\/TherapeuticBiologicApplications\/ucm080832.pdf(accessed 25 July 2014)"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0470|cit470","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.06.017","article-title":"Aspirin treatment failure and the risk of recurrent stroke and death among patients with ischemic stroke","volume":"22","author":"Georgiadis","year":"2013","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0471|cit471","first-page":"e331","article-title":"Renal function, hydration status, and outcome from stroke after thrombolysis","volume":"41","author":"Gorman","year":"2010","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0472|cit472","first-page":"723","article-title":"The NINDS Stroke Study Group Response (author's response)","volume":"324","author":"Grotta J for the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"2002","journal-title":"BMJ"},{"issue":"S1","key":"10.1002\/14651858.CD000213.pub3-BIB0473|cit473","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.surneu.2007.07.079","article-title":"Intravenous rt-PA: a tenth anniversary reflection","volume":"68","author":"Grotta","year":"2007","journal-title":"Surgical Neurology"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0476|cit474","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/labmed\/27.5.296","article-title":"Heart treatment reduces damage from stroke","volume":"27","author":"Grotta","year":"1996","journal-title":"Laboratory Medicine"},{"issue":"3\/4","key":"10.1002\/14651858.CD000213.pub3-BIB0477|cit475","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/jscd.2002.130044","article-title":"The NINDS Stroke Study group responses","volume":"11","author":"Grotta","year":"2002","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0474|cit476","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/01.STR.30.8.1528","article-title":"Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy","volume":"30","author":"Grotta","year":"1999","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0475|cit477","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.STR.32.3.661","article-title":"Clinical deterioration following improvement in the NINDS rt-PA stroke trial","volume":"32","author":"Grotta","year":"2001","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0478|cit478","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0196-0644(97)99996-0","article-title":"Myths regarding the NINDS rt-PA stroke trial: setting the record straight","volume":"30","author":"Haley","year":"1997","journal-title":"Annals of Emergency Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0479|cit479","first-page":"e164","article-title":"Two hour improvement of patients in the NINDS t-PA Trials and prediction of final outcome","volume":"42","author":"Hemmen","year":"2011","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0480|cit480","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1161\/STROKEAHA.110.608919","article-title":"Two-hour improvement of patients in the National Institute of Neurological Disorders and Stroke trials and prediction of final outcome","volume":"42","author":"Hemmen","year":"2011","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0481|cit481","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.06.001","article-title":"Analysis of the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Studies following European Cooperative Acute Stroke Study III patient selection criteria","volume":"19","author":"Hemmen","year":"2010","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0482|cit482","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1740774508094404","article-title":"Methods and processes for the reanalysis of the NINDs tissue plasminogen activator for acute ischemic stroke treatment trial","volume":"5","author":"Hertzberg","year":"2008","journal-title":"Clinical Trials: Journal of the Society for Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0483|cit483","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.annemergmed.2009.03.019","article-title":"A graphic reanalysis of the NINDS Trial","volume":"54","author":"Hoffman JR Schriger","year":"2009","journal-title":"Annals of Emergency Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0484|cit484","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/STROKEAHA.109.571083","article-title":"Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke","volume":"41","author":"Hong","year":"2010","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0485|cit485","first-page":"e389","article-title":"Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke","volume":"41","author":"Hong","year":"2010","journal-title":"Stroke"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0486|cit486","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/01.STR.0000140891.70547.56","article-title":"Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial","volume":"35","author":"Ingall","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0487|cit487","first-page":"125","article-title":"Initial findings of the rt-PA acute stroke treatment review panel","volume":"16 Suppl 4","author":"Ingall","year":"2003","journal-title":"Cerebrovascular Diseases"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0488|cit488","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/01.STR.0000242290.01174.9e","article-title":"Association of serial biomarkers with acute ischemic stroke: the National Institute of Neurological Disorders and stroke recombinant tissue plasminogen activator stroke study","volume":"37","author":"Jauch","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0489|cit489","first-page":"419","article-title":"Serial biochemical markers are associated with acute ischemic stroke in the NINDS rtPA stroke study","volume":"36","author":"Jauch","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0490|cit490","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/01.STR.0000047102.61863.E3","article-title":"Predicting outcome in ischemic stroke: external validation of predictive risk models","volume":"34","author":"Johnston","year":"2003","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0491|cit491","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1161\/01.STR.0000109768.98392.4D","article-title":"Risk adjustment effect on stroke clinical trials","volume":"35","author":"Johnston","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0492|cit492","first-page":"256","article-title":"Risk adjustment uncovers greater treatment effect in NINDS tPA trial","volume":"34","author":"Johnston","year":"2003","journal-title":"Stroke"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0493|cit493","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/01.STR.0000090842.81076.68","article-title":"Are patients with acutely recovered cerebral ischemia more unstable?","volume":"34","author":"Johnston","year":"2003","journal-title":"Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0494|cit494","first-page":"34","article-title":"Are asymptomatic intracranial hemorrhages really innocuous?","volume":"16","author":"Kent","year":"2003","journal-title":"Cerebrovascular Diseases"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0495|cit495","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1161\/STROKEAHA.110.593632","article-title":"Strokes with minor symptoms. An exploratory analysis of the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trials","volume":"41","author":"Khatri","year":"2010","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0496|cit496","first-page":"576","article-title":"Modified Rankin score group distributions as a clinical trial end point: A NINDS tPA stroke study reanalysis","volume":"38","author":"Khatri","year":"2007","journal-title":"Stroke"},{"key":"#cr-split#-10.1002\/14651858.CD000213.pub3-BIB0497|cit497.1","unstructured":"Kirchoff KF Shaftman SR Zach V Tanne D Tilley BC Gorman M Utility of measuring distal motor function in the NIHSS: correlation with motor arm function Proceedings of the American Academy of Neurology 62nd Annual Meeting 2010. 10-17 April 2010"},{"key":"#cr-split#-10.1002\/14651858.CD000213.pub3-BIB0497|cit497.2","unstructured":"Toronto, Canada 2010 Abst. P03.054"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0498|cit498","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM199803123381112","article-title":"Should thrombolytic therapy be the first-line treatment for acute ischemic stroke?","volume":"338","author":"Kirshner","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0499|cit499","first-page":"217","article-title":"The effect of race and gender on patterns of rt-PA use within a population","volume":"12","author":"Kleindorfer","year":"2003","journal-title":"Journal of Stroke and Cardiovascular Diseases"},{"issue":"21","key":"10.1002\/14651858.CD000213.pub3-BIB0500|cit500","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199605233342114","article-title":"Tissue plasminogen activator for acute ischaemic stroke","volume":"334","author":"Koroshetz","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0501|cit501","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.annemergmed.2004.06.021","article-title":"The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and stroke recombinant tissue plasminogen activator stroke study","volume":"45","author":"Kwiatkowski","year":"2005","journal-title":"Annals of Emergency Medicine"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0502|cit502","first-page":"288","article-title":"The NINDS rt-PA stroke study: sustained benefit at one year","volume":"29","author":"Kwiatkowski","year":"1998","journal-title":"Stroke"},{"issue":"23","key":"10.1002\/14651858.CD000213.pub3-BIB0503|cit503","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199906103402302","article-title":"Effects of tissue plasminogen activator for acute ischaemic stroke at one year","volume":"340","author":"Kwiatkowski","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"7339","key":"10.1002\/14651858.CD000213.pub3-BIB0504|cit504","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bmj.324.7339.723","article-title":"Alteplase for stroke: money and optimistic claims buttress the \"brain attack\" campaign","volume":"324","author":"Lenzer","year":"2002","journal-title":"BMJ"},{"issue":"7373","key":"10.1002\/14651858.CD000213.pub3-BIB0505|cit505","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/bmj.325.7373.1131","article-title":"Controversial stroke trial is under review following BMJ report","volume":"325","author":"Lenzer","year":"2002","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0506|cit506","first-page":"757","article-title":"Questioning thrombolytic use for cerebrovascular accidents","volume":"16","author":"Li","year":"1998","journal-title":"Journal of Emergency Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0507|cit507","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jstrokecerebrovasdis.2004.11.002","article-title":"Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome","volume":"14","author":"Libman","year":"2005","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0508|cit508","first-page":"e117","article-title":"Hyperdense ischemic infarcts in the NINDS rt-PA trials reflect hyperglycemia, not hemorrhage","volume":"40","author":"Liebeskind","year":"2009","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0509|cit509","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000175766","article-title":"Does body weight influence the response to intravenous tissue plasminogen activator in stroke patients?","volume":"27","author":"Lou","year":"2009","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0510|cit510","first-page":"530","article-title":"Does stroke patient's weight influence the response to intravenous t-PA?","volume":"39","author":"Lou","year":"2008","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0511|cit511","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1161\/01.STR.30.11.2347","article-title":"Underlying structure of the National Institutes of Health stroke scale. Results of a factor analysis","volume":"30","author":"Lyden","year":"1999","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0512|cit512","first-page":"56","article-title":"Underlying structure of the NIH stroke scale: results of a factor analysis","volume":"31","author":"Lyden","year":"2000","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0513|cit513","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.annemergmed.2005.01.030","article-title":"Stroking the data: re-analysis of the NINDS trial","volume":"45","author":"Magid","year":"2005","journal-title":"Annals of Emergency Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0514|cit514","first-page":"Abst. 2374","article-title":"A new more sensitive method to assess balance among stroke patient populations","volume":"43","author":"Mandava","year":"2012","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0515|cit515","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/STROKEAHA.109.574103","article-title":"A matching algorithm to address imbalances in study populations. Application to the National Institute of Neurological Diseases and Stroke Recombinant Tissue Plasminogen Activator Acute Stroke Trial","volume":"41","author":"Mandava","year":"2010","journal-title":"Stroke"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD000213.pub3-BIB0516|cit516","first-page":"172","article-title":"A method to generate a control population for acute ischemic stroke trials: validation with NINDS and application to a phaseI treatment series","volume":"27","author":"Mandava","year":"2009","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0517|cit517","first-page":"e84","article-title":"Hyperglycemia worsens outcome after rt-PA in the large artery stroke subtype","volume":"42","author":"Mandava","year":"2011","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0518|cit518","first-page":"e164","article-title":"Gender and race interact to influence outcome of ischemic stroke after treatment with rt-PA","volume":"42","author":"Mandava","year":"2011","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0519|cit519","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1161\/STROKEAHA.113.001116","article-title":"Explicit consideration of baseline factors to assess recombinant tissue-type plasminogen activator response with respect to race and sex","volume":"44","author":"Mandava","year":"2013","journal-title":"Stroke"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213.pub3-BIB0520|cit520","first-page":"277","article-title":"Gender differences in outcome following rt-PA are mainly due to the influence of race","volume":"35","author":"Mandava","year":"2013","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0521|cit521","first-page":"263","article-title":"How gender and race interact to influence outcome of ischemic stroke after treatment with rt-PA","volume":"31","author":"Mandava","year":"2011","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0522|cit522","first-page":"255","article-title":"Hyperglycemia is an independent risk factor for poor outcome after rt-PA only in the large artery stroke subtype","volume":"31","author":"Mandava","year":"2011","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0523|cit523","first-page":"439","article-title":"Evaluation of subject matching methods to adjust for imbalances in stroke trials","volume":"33","author":"Mandava","year":"2012","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0525|cit524","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/ewjm.176.3.192","article-title":"Truths about the NINDS study: setting the record straight","volume":"176","author":"Mann","year":"2002","journal-title":"Western Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0524|cit525","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.STR.0000152953.71415.01","article-title":"NINDS Reanalysis Committee's reanalysis of the NINDS trial (response)","volume":"36","author":"Mann","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0526|cit526","first-page":"244","article-title":"Earlier treatment associated with better outcome in the NINDS TPA Stroke Study","volume":"30","author":"Marler","year":"1999","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0527|cit527","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1212\/WNL.55.11.1649","article-title":"Early stroke treatment associated with better outcome. The NINDS rt-PA Stroke Study","volume":"55","author":"Marler","year":"2000","journal-title":"Neurology"},{"issue":"21","key":"10.1002\/14651858.CD000213.pub3-BIB0528|cit528","first-page":"1406","article-title":"Tissue plasminogen activator for acute ischaemic stroke","volume":"334","author":"Marler","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0529|cit529","first-page":"e331","article-title":"No differential effect of tPA based on final stroke etiologic subtype: A reanalysis of the NINDS tPA Trial","volume":"41","author":"Martini","year":"2010","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0530|cit530","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.01.002","article-title":"Dosing errors did not have a major impact on outcome in the NINDS t-PA Stroke Study","volume":"20","author":"Messe","year":"2011","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0531|cit531","first-page":"524","article-title":"Congestive heart failure is associated with poor outcome at 6 months in patients with ischemic stroke","volume":"36","author":"Mohammad","year":"2005","journal-title":"Stroke"},{"issue":"Suppl 167","key":"10.1002\/14651858.CD000213.pub3-BIB0532|cit532","first-page":"28","article-title":"Recent results from the NINDS-tPA trial","volume":"94","author":"Morgenstern","year":"1996","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0533|cit533","first-page":"503","article-title":"IV rt-PA improves arterial recanalization rates and reduces infarct volumes in subjects with hyperdense artery sign on baseline CT","volume":"38","author":"Nichols","year":"2007","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0534|cit534","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.10.002","article-title":"Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography","volume":"17","author":"Nichols","year":"2008","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0535|cit535","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12028-012-9803-0","article-title":"Long-term outcomes of post-thrombolytic intracerebral hemorrhage in ischemic stroke patients","volume":"18","author":"Norby","year":"2013","journal-title":"Neurocritical Care"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0536|cit536","unstructured":"O'Fallon M Asplund K Goldfrank LR Hertzberg V Ingall TJ Louis TA The NINDS trial on t-PA in acute ischemic stroke revisited. Main results from an independent re-analysis of primary data Program and abstract book. 12th Nordic Meeting on Cerebrovascular Diseases; 2003 Sep 17-20; Oslo 2003 27"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0537|cit537","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000255974","article-title":"Day-90 acute ischemic stroke outcomes can be derived from early functional activity level","volume":"29","author":"Ovbiagele","year":"2010","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0538|cit538","first-page":"496","article-title":"The smoking-thrombolysis paradox applies to stroke as well as MI: smoking has early beneficial effects following intravenous thrombolysis for acute ischemic stroke","volume":"36","author":"Ovbiagele","year":"2005","journal-title":"Stroke"},{"issue":"22","key":"10.1002\/14651858.CD000213.pub3-BIB0539|cit539","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1001\/jama.286.22.2830","article-title":"Lack of clinical significance of early ischaemic changes on computed tomography in acute stroke","volume":"286","author":"Patel","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0540|cit540","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/S0140-6736(05)75572-0","article-title":"Early treatment of stroke with t-PA provides uncertain long-term benefits","volume":"353","author":"Pearson","year":"1999","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213.pub3-BIB0541|cit541","first-page":"407","article-title":"Relating ASPECTS infarct location to stroke disability in the NINDS rt-PA trial: proof of concept study using penalized logistic regression","volume":"35","author":"Phan","year":"2013","journal-title":"Cerebrovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0542|cit542","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1159\/000351147","article-title":"Proof of concept study: Relating infarct location to stroke disability in the NINDS rt-PA Trial","volume":"35","author":"Phan","year":"2013","journal-title":"Cerebrovascular Diseases"},{"issue":"21","key":"10.1002\/14651858.CD000213.pub3-BIB0543|cit543","first-page":"1406","article-title":"Tissue plasminogen activator for acute ischaemic stroke","volume":"334","author":"Quereshi","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0544|cit544","first-page":"658","article-title":"Is a maximum dose of 90 mg of recombinant tissue plasminogen activator in patients weighing greater than 90 kg justified?","volume":"37","author":"Qureshi","year":"2006","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0545|cit545","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1552-6569.2012.00737.x","article-title":"Clinical-radiological severity mismatch phenomenon: patients with severe neurological deficits without matching infarction on computed tomographic scan","volume":"23","author":"Qureshi","year":"2013","journal-title":"Journal of Neuroimaging"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0546|cit546","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1212\/01.wnl.0000208407.69544.5a","article-title":"Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?","volume":"66","author":"Qureshi","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0547|cit547","first-page":"493","article-title":"Analysis of patients with hyperdense artery sign in the National Institute of Neurological Diseases and stroke tissue plasminogen activator trial","volume":"36","author":"Qureshi","year":"2005","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0548|cit548","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1212\/01.wnl.0000242756.00084.f9","article-title":"African American women have poor long-term survival following ischemic stroke","volume":"67","author":"Qureshi","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0549|cit549","first-page":"e245","article-title":"Clinical-radiological severity mismatch phenomenon: patients with severe neurological deficits without matching infarction on computed tomographic scan","volume":"42","author":"Qureshi","year":"2011","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0550|cit550","first-page":"532","article-title":"Aspirin failure does not increase the risk of recurrent stroke or death among patients with ischemic stroke","volume":"38","author":"Qureshi","year":"2007","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0551|cit551","first-page":"Abst. 209","article-title":"The most accurate definition of clinically relevant hemorrhagic transformation after thrombolytic therapy for stroke: analysis of the NINDS-TPA trials","volume":"43","author":"Rao","year":"2012","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0552|cit552","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.03.006","article-title":"Time of day, outcome, and response to thrombolytic therapy: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience","volume":"19","author":"Rhoney","year":"2010","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0553|cit553","first-page":"Abst. 3797","article-title":"Patients with diabetes and previous ischemic strokes in the National Institute of NINDS trial","volume":"43","author":"Sangha","year":"2012","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0554|cit554","first-page":"e116","article-title":"The iScore predicts efficacy and risk of bleeding in the NINDS t-PA stroke trial","volume":"43","author":"Saposnik","year":"2012","journal-title":"Stroke"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0561|cit555","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1161\/STROKEAHA.107.487009","article-title":"Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm","volume":"38","author":"Saver","year":"2007","journal-title":"Stroke"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0562|cit556","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archneur.61.7.1066","article-title":"Number needed to treat estimates incorporating effects over the entire range of clinical outcomes. Novel derivation method and application to thrombolytic therapy for acute stroke","volume":"61","author":"Saver","year":"2004","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0555|cit557","first-page":"Abst. 2816","article-title":"Relation between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset","volume":"43","author":"Saver","year":"2012","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0556|cit558","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/STROKEAHA.111.636928","article-title":"Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset","volume":"43","author":"Saver","year":"2012","journal-title":"Stroke"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0557|cit559","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/STROKEAHA.110.583807","article-title":"Graphic reanalysis of the two NINDS-tPA trials confirms substantial treatment benefit","volume":"41","author":"Saver","year":"2010","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0558|cit560","first-page":"e205","article-title":"Impact of treatment on individual patients in the two NINDS-TPA trials. Normalized change in NIHSS score confirms benefit graphically and statistically","volume":"40","author":"Saver","year":"2009","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0559|cit561","first-page":"622","article-title":"Robust confirmation of treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials","volume":"37","author":"Saver","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0560|cit562","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.STR.0000254580.39297.3c","article-title":"Confirmation of tPA treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials","volume":"38","author":"Saver","year":"2007","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0563|cit563","first-page":"576","article-title":"Rankin shift analysis of the NINDS and ECASS-II trials","volume":"38","author":"Savitz","year":"2007","journal-title":"Stroke"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0564|cit564","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1161\/STROKEAHA.107.489351","article-title":"Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials","volume":"38","author":"Savitz","year":"2007","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0565|cit565","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3949\/ccjm.63.2.77","article-title":"Therapy for acute ischemic stroke: the door opens. Interpreting the NINDS rt-PA stroke study","volume":"63","author":"Sila","year":"1996","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"1-2","key":"10.1002\/14651858.CD000213.pub3-BIB0566|cit566","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jns.2008.03.012","article-title":"Blood pressure declines and less favorable outcomes in the NINDS tPA stroke study","volume":"271","author":"Silver","year":"2008","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0567|cit567","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.STR.0000154861.96280.29","article-title":"NINDS stroke trial data reanalysis leaves issues unresolved (response)","volume":"36","author":"Smith","year":"2005","journal-title":"Stroke"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0568|cit568","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5694\/j.1326-5377.2003.tb05603.x","article-title":"Thromobolysis for acute ischaemic stroke: revisiting the evidence","volume":"179","author":"Smith","year":"2003","journal-title":"Medical Journal of Australia"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0569|cit569","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000330375","article-title":"Application of regression to analyze ischemic stroke volume in NINDS rt-PA clinical trials","volume":"37","author":"Swearingen","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0570|cit570","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1212\/WNL.53.2.424","article-title":"Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey","volume":"53","author":"Tanne","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0571|cit571","first-page":"279","article-title":"Antiphospholipid antibodies and outcome of acute ischemic stroke in the NINDS rt-PA Stroke Trial","volume":"34","author":"Tanne","year":"2003","journal-title":"Stroke"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0572|cit572","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1212\/01.WNL.0000086809.46485.A1","article-title":"Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA stroke trial","volume":"61","author":"Tanne","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0573|cit573","first-page":"704","article-title":"Effect of elevated hemostatic markers on outcome after rt-PA therapy for acute ischemic stroke: results from the NINDS rt-PA stroke trial","volume":"37","author":"Tanne","year":"2006","journal-title":"Stroke"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0574|cit574","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/01.STR.0000226897.43749.27","article-title":"Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke","volume":"37","author":"Tanne","year":"2006","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0575|cit575","first-page":"182","article-title":"Predictors of favourable outcome","volume":"6","author":"The NINDS TPA Stroke Trial","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0576|cit576","first-page":"2828","article-title":"Effect of rt-PA on CT lesion volume over time","volume":"31","author":"The NINDS rt-PA Stroke Study Group","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0577|cit577","unstructured":"The NINDS rt-PA Stroke Study Group Effect of rt-PA on ischaemic stroke lesion size by computed tomography: preliminary results from the NINDS rt-PA stroke trial Proceedings of the 23rd International Joint Conference on Stroke and Cerebral Circulation; 1998 Feb 5-7; Orlando (FL) 1998 287"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0578|cit578","first-page":"241","article-title":"Tissue plasminogen activator for minor strokes: the NINDS rt-PA stroke study experience","volume":"35","author":"The NINDS rt-PA Stroke Study Group","year":"2005","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0579|cit579","first-page":"181","article-title":"Predictors of an unfavourable outcome","volume":"6","author":"The NINDS rt-PA Stroke Trial","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0580|cit580","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/01.STR.28.11.2119","article-title":"Generalised efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA stroke trial","volume":"28","author":"The NINDS t-PA Stroke Study Group","year":"1997","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0581|cit581","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.STR.28.11.2109","article-title":"Intracerebral haemorrhage after intravenous t-PA therapy for ischaemic stroke. The NINDS t-PA Stroke Study Group","volume":"28","author":"The NINDS t-PA Stroke Study Group","year":"1997","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0582|cit582","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.annemergmed.2005.02.013","article-title":"Recombinant tissue plasminogen activator for minor strokes: The National Institute of Neurological Disorders and Stroke rt-PA stroke study experience","volume":"46","author":"The National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group","year":"2005","journal-title":"Annals of Emergency Medicine"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0583|cit583","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/01.STR.28.8.1530","article-title":"A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centres and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group","volume":"28","author":"The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group","year":"1997","journal-title":"Stroke"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0584|cit584","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1161\/01.STR.31.12.2912","article-title":"Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group","volume":"31","author":"The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group","year":"2000","journal-title":"Stroke"},{"issue":"24","key":"10.1002\/14651858.CD000213.pub3-BIB0585|cit585","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischaemic stroke","volume":"333","author":"The National Institute of Neurological Disorders and Stroke rt-PA stroke study group","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0586|cit586","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/archneur.1997.00550240020008","article-title":"Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group","volume":"54","author":"Tilley","year":"1997","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0587|cit587","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/ewjm.176.3.194","article-title":"Why were the benefits of tPA exaggerated?","volume":"176","author":"Trotter","year":"2002","journal-title":"Western Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0588|cit588","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/01.STR.31.1.231","article-title":"'Self-fulfilling prophecy' or recognition requires a concept of perception","volume":"31","author":"Kummer","year":"2000","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0589|cit589","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/ewjm.176.3.198","article-title":"Thrombolysis for acute ischemic stroke: still a treatment for the few by the few","volume":"176","author":"Wardlaw","year":"2002","journal-title":"Western Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0590|cit590","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.annemergmed.2005.05.007","article-title":"Subgroups, reanalysis, and other dangerous things","volume":"46","author":"Wears","year":"2005","journal-title":"Annals of Emergency Medicine"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0591|cit591","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1161\/01.STR.0000030108.47462.4F","article-title":"Safety of tissue plasminogen activator for acute stroke in menstruating women","volume":"33","author":"Wein","year":"2002","journal-title":"Stroke"},{"issue":"Abst. ATP379","key":"10.1002\/14651858.CD000213.pub3-BIB0592|cit592","first-page":"1","article-title":"The relation between destination on hospital discharge and final 3 month disability outcome in acute ischemic stroke","volume":"44","author":"Zhang","year":"2013","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0593|cit593","first-page":"445","article-title":"Clinical efficacy of urokinase in patients with cerebral thrombosis: multicentre double blind study","volume":"19","author":"Ohtomo","year":"1985","journal-title":"Kiso-to-Rinshyo (Basic and Clinical)"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0594|cit594","first-page":"711","article-title":"Clinical efficacy of urokinase in the treatment of cerebral thrombosis. Multi-center double-blind study in comparison with placebo","volume":"13","author":"Ohtomo","year":"1985","journal-title":"Clinical Evaluation"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0595|cit595","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","article-title":"PROACT: A phase II randomised trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke","volume":"29","author":"Zoppo","year":"1998","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0596|cit596","first-page":"189","article-title":"Intra-arterial middle cerebral artery pro-urokinase acute stroke study","volume":"6","author":"Zoppo","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0597|cit597","doi-asserted-by":"crossref","first-page":"s44","DOI":"10.1185\/030079902125000723","article-title":"The role of recombinant pro-urokinase (r-pro-UK) and intra-arterial thrombolysis in acute ischaemic stroke: the PROACT trials","volume":"18","author":"Furlan","year":"2002","journal-title":"Current Medical Research and Opinion"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0598|cit598","first-page":"171","article-title":"The clinical trials acceleration program: experience from the Prolyse in Acute Cerebral Thromboembolism Trial (PROACT)","volume":"27","author":"Furlan","year":"1996","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0599|cit599","first-page":"CT 3","article-title":"Education, facilitation and motivation at clinical sites in an effort to increase patient enrolment in the PROACT Stroke Study","volume":"29","author":"Gutterman","year":"1998","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0600|cit600","first-page":"e353","article-title":"Intracranial hemorrhage and its relationship to reperfusion and clinical outcome: an exploratory analysis of the PROACT II Trial","volume":"41","author":"Khatri","year":"2010","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0601|cit601","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/STROKEAHA.112.671495","article-title":"Is intra-arterial thrombolysis beneficial for M2 occlusions? Subgroup analysis of the PROACT-II trial","volume":"44","author":"Rahme","year":"2013","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0602|cit602","first-page":"e64","article-title":"Futile angiographic reperfusion in the PROACT II Trial: an exploratory analysis","volume":"42","author":"Salsberg","year":"2011","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0603|cit603","unstructured":"Furlan A Higashida R Wechsler L Schulz G PROACT II Investigators PROACT II: recombinant prourokinase (r-ProUK) in acute cerebral thromboembolism Proceedings of the 23rd Joint International Conference on Stroke and Cerebral Circulation; 1998 Feb 5-7; Orlando (FL) USA 1998"},{"issue":"21","key":"10.1002\/14651858.CD000213.pub3-BIB0604|cit604","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intraarterial pro-urokinase for acute ischaemic stroke. The PROACT II Study: a randomised controlled trial. Prolyse in Acute Cerebral Thromboembolism","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0605|cit605","doi-asserted-by":"crossref","first-page":"s44","DOI":"10.1185\/030079902125000723","article-title":"The role of recombinant pro-urokinase (r-pro-UK) and intra-arterial thrombolysis in acute ischaemic stroke: the PROACT trials. Prolyse in Acute Cerebral Thromboembolism","volume":"18 Suppl 2","author":"Furlan","year":"2002","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0606|cit606","first-page":"234","article-title":"Recombinant prourokinase (r-ProUK) in acute cerebral thromboembolism: initial trial results. The PROACT investigators","volume":"30","author":"Furlan","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0607|cit607","first-page":"e3","article-title":"Early ischemic signs should not be used as exclusion criteria in thrombolysis trials","volume":"35","author":"Furlan","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0608|cit608","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1161\/01.STR.0000107774.74679.16","article-title":"Early ischemic signs should not be used as exclusion criteria in thrombolysis trials","volume":"35","author":"Hamann","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0609|cit609","first-page":"e7","article-title":"Predicting functional outcome after intra-arterial thrombolysis: aspects of ASPECTS","volume":"35","author":"Hill","year":"2004","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0610|cit610","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/01.STR.0000237060.21472.47","article-title":"Sex-based differences in the effect of intra-arterial treatment of stroke. Analysis of the PROACT-2 Study","volume":"37","author":"Hill","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0611|cit611","first-page":"706","article-title":"Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study","volume":"37","author":"Hill","year":"2006","journal-title":"Stroke"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0612|cit612","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/01.STR.0000082483.37127.D0","article-title":"Selection of acute ischaemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS","volume":"34","author":"Hill","year":"2003","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0613|cit613","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/WNL.57.9.1603","article-title":"Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial","volume":"57","author":"Kase","year":"2001","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0614|cit614","first-page":"A260","article-title":"Symptomatic intracranial hemorrhage after intraarterial thrombolysis with recombinant prourokinase in acute ischaemic stroke: The PROACT II Study","volume":"54 Suppl 3","author":"Kase","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0615|cit615","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/01.STR.0000126043.83777.3a","article-title":"Regional angiographic grading system for collateral flow: correlation with cerebral infarction in patients with middle cerebral artery occlusion","volume":"35","author":"Kim","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0616|cit616","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/STROKEAHA.112.671495","article-title":"Is intra-arterial thrombolysis beneficial for M2 occlusions? Subgroup analysis of the PROACT-II trial","volume":"44","author":"Rahme","year":"2013","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0617|cit617","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/str.32.suppl_1.336-b","article-title":"Angiographic collaterals in acute stroke - relationship to clinical presentation and outcome: The PROACT II Trial","volume":"32","author":"Roberts","year":"2001","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0618|cit618","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.STR.0000018011.66817.41","article-title":"Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischaemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial","volume":"33","author":"Roberts","year":"2002","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0619|cit619","first-page":"278","article-title":"Effect of intraarterial prourokinase on CT infarct volume: results of PROACT II","volume":"31","author":"Roberts","year":"2000","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0620|cit620","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.STR.0000237086.85164.92","article-title":"Sex-based differences in the effect of intra-arterial treatment of stroke: a plea to stop torturing the old data and do large trials!","volume":"37","author":"Sandercock","year":"2006","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0621|cit621","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/01.STR.0000107771.06671.7E","article-title":"Predicting functional outcome after intra-arterial thrombolysis: aspects of ASPECTS","volume":"35","author":"Saposnik","year":"2004","journal-title":"Stroke"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0622|cit622","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/STROKEAHA.107.490417","article-title":"Intra-arterial fibrinolysis for acute ischemic stroke. The message of MELT","volume":"38","author":"Saver","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0623|cit623","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/str.32.suppl_1.319","article-title":"Factors influencing outcome and treatment effect in PROACT II","volume":"32","author":"Wechsler","year":"2001","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0624|cit624","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/01.STR.0000068782.15297.28","article-title":"Factors influencing outcome and treatment effects in PROACT II","volume":"34","author":"Wechsler","year":"2003","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0625|cit625","first-page":"542","article-title":"Early intravenous thrombolysis with recombinant tissue plasmogen activator for acute cerebral infarction","volume":"15","author":"Wang","year":"2003","journal-title":"Chinese Critical Care Medicine"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0626|cit626","first-page":"678","article-title":"Clinical study on early intravenous thrombolysis with rt-PA for acute cerebral infarction","volume":"39","author":"Wang","year":"2006","journal-title":"Chinese Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0627|cit627","first-page":"457","article-title":"Thrombolytic therapy using Actilyse (rt-PA) in patients with acute cerebral infarction","volume":"15","author":"Zeng","year":"2006","journal-title":"Chinese Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0628|cit628","unstructured":"Bao Z Clinical revaluation of intravenous thrombolysis with urokinase in treatment of acute cerebral infarction Proceedings of the 4th International Conference on Research Advances in Cerebrovascular Disease; 2003 Oct 13-15; China 2003 201 3"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0629|cit629","unstructured":"Boehringer Mannheim Double-blind, placebo-controlled, randomized multicenter study to evaluate the efficacy and safety of two doses of reteplase (r-PA_) (10 MU; 10 MU + 10 MU) in acute cerebral ischemia (MF 4398) Protocol 1994"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0630|cit630","first-page":"531","article-title":"The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke (the CLEAR stroke trial): final results from Tier I and II","volume":"39","author":"Pancioli","year":"2008","journal-title":"Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0631|cit631","first-page":"Abst 0270","article-title":"The usefulness of clinical-DWI mismatch in the treatment of acute ischemic stroke with reperfusion therapies","volume":"16","author":"D\u00e1valos","year":"2003","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0632|cit632","unstructured":"Boehringer Ingelheim Defuse Powerpoint presentation"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0633|cit633","first-page":"46","article-title":"Hemodynamic stability during remifentanil or sufentanil anaesthesia in patients undergoing carotid endarterectomy (CE)","volume":"82 Suppl 1","author":"DeWinter","year":"1999","journal-title":"British Journal of Anaesthesia"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0634|cit634","first-page":"60","article-title":"Small-dose aspirin plus lumbrukinase in improving neurological function of patients with acute cerebral infarction","volume":"10","author":"Ding","year":"2006","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0635|cit635","first-page":"76","article-title":"Intravenous versus intra-arterial urokinase thrombolysis in acute ischemic stroke. Randomised study of 27 patients","volume":"10","author":"Ducrocq","year":"2000","journal-title":"Cerebrovascular Diseases"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0636|cit636","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0150-9861(05)83018-4","article-title":"Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke","volume":"32","author":"Ducrocq","year":"2005","journal-title":"Journal of Neuroradiology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0637|cit637","unstructured":"Mori E Informaiton about the EAST II trial [personal communication] Email to JM Wardlaw"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0638|cit638","first-page":"251","article-title":"Edinburgh Stroke Trial. A pilot study of intra-arterial thrombolysis for acute ischaemic stroke","volume":"57","author":"Wardlaw","year":"1994","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0641|cit639","first-page":"106","article-title":"The European multicentre four-arm trial in acute stroke project (EMFATAS): A European Union work - program on health research","volume":"9","author":"Fieschi","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0639|cit640","unstructured":"Fieschi C Hacke W Kaste M EMFATAS Study Group Early protocol of the European Multicentre Four-arm Trial in Acute Stroke (EMFATAS) of combination therapy in acute ischaemic stroke The Challenge of Stroke. The Lancet Confererence; 1998 Oct 15-16; Montreal 1998 36"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0640|cit641","first-page":"192","article-title":"The EMFATAS project: a four-arm safety and efficacy European trial","volume":"6","author":"Fieschi","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0642|cit642","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000068510","article-title":"Acute stroke trials: the problems of local investigators?","volume":"49","author":"Toni","year":"2003","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0644|cit643","unstructured":"Derex L Outcome of the EMS Trial patients without angiographically demonstrated arterial occlusion 5th Thrombolysis in Acute Stroke Symposium, 1998 May 1-2; Bethesda (MD), USA 1998"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0643|cit644","first-page":"685","article-title":"Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset","volume":"22","author":"Derex","year":"2001","journal-title":"American Journal of Neuroradiology"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0645|cit645","first-page":"273","article-title":"Combined intra-arterial and intravenous tPA for stroke","volume":"28","author":"Emergency Management of Stroke (EMS) Investigators","year":"1997","journal-title":"Stroke"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0646|cit646","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1161\/01.STR.30.12.2598","article-title":"Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke. Emergency Management of Stroke (EMS) Bridging Trial","volume":"30","author":"Lewandowski","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0647|cit647","unstructured":"Sandercock P Interim results of EMS trial in acute ischaemic stroke [personal communication] Email to JM Wardlaw 1997"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0648|cit648","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1052-3057(99)80077-9","article-title":"Combined intravenous and intraarterial thrombolytic therapy for treatment of an acute ischemic stroke: a case report","volume":"8","author":"Swarnkar","year":"1999","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0649|cit649","first-page":"184","article-title":"Combined intravenous and intra-arterial thrombolysis versus intra-arterial thrombolysis alone: preliminary safety and clot lysis","volume":"6","author":"The EMS Bridging Trial Investigators","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0650|cit650","first-page":"9","article-title":"Antithrombosis enzyme vs dextran-40 in treatment of acute cerebral infarction","volume":"4","author":"Fan","year":"2001","journal-title":"Henan Journal of Practical Nervous Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0651|cit651","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/01.STR.0000054627.69159.C2","article-title":"Emerging therapies for acute ischemic stroke: new therapies on trial","volume":"34","author":"Fisher","year":"2003","journal-title":"Stroke"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0652|cit652","first-page":"948","article-title":"Clinical observation of treatment through intravenous thrombolysis with low dose urokinase in 36 patients with advanced cerebral infarction","volume":"11","author":"Fu","year":"2004","journal-title":"Chinese Journal of Primary Medicine and Pharmacy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0653|cit653","first-page":"108","article-title":"Is intravenous t-PA treatment beneficial in acute ischemic stroke related to internal carotid dissection?","volume":"23","author":"Fuentes","year":"2007","journal-title":"Cerebrovascular Diseases"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0654|cit654","first-page":"604","article-title":"Intravenous drip of urokinase combined with low molecular weight heparin in the treatment of acute cerebral infarction","volume":"21","author":"Geng","year":"2004","journal-title":"Practical Journal of Medicine and Pharmacy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0655|cit655","first-page":"80","article-title":"Intravenous thrombolysis has a beneficial effect on clinical course but not infarct size in patients with supratentorial brain infarct","volume":"19","author":"Hartmann","year":"2005","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0656|cit656","unstructured":"Kumana C Trial of intravenous streptokinase in Chinese patients with acute ischaemic stroke Unpublished"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0657|cit657","first-page":"378","article-title":"31 cases clinical report of snake venom IV on acute cerebral infarction","volume":"22","author":"Huang","year":"1996","journal-title":"Chinese Journal of Nervous and Mental Diseases"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0658|cit658","first-page":"453","article-title":"Lumbrokinase in treating cerebral infarction","volume":"19","author":"Huang","year":"2000","journal-title":"Chinese Journal of New Drugs and Clinical Remedy"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0659|cit659","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1197\/j.aem.2006.03.559","article-title":"A trial of therapeutic hypothermia via endovascular approach in awake patients with acute ischemic stroke: methodology","volume":"13","author":"Guluma","year":"2006","journal-title":"Academic Emergency Medicine"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0660|cit660","unstructured":"Hemmem TM Cruz-Flores S Martin-Schild S Gomes JA Wijman CA Rapp KS Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L) asa.scientificposter.com\/epsView.cfm?pid=CTP43&vr=2008"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0661|cit661","unstructured":"Hemmen TM Cruz-Flores S Martin-Schild S Gomes JA Wijman CA Rapp KS Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L) Proceedings of the International Stroke Conference; 2008 Feb 20-22; New Orleans (LA), USA American Stroke Associate 2008 CTP43"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0662|cit662","first-page":"706","article-title":"Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L)","volume":"37","author":"Hemmen","year":"2006","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0663|cit663","first-page":"e246","article-title":"Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results","volume":"41","author":"Hemmen","year":"2010","journal-title":"Stroke"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0664|cit664","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1161\/STROKEAHA.110.592295","article-title":"Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L) final results","volume":"41","author":"Hemmen","year":"2010","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0665|cit665","first-page":"12","article-title":"Factors that determine cooling rate in a trial of endovascular hypothermia for acute stroke-the ICTUS-L trial","volume":"5","author":"Lyden","year":"2010","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0667|cit666","unstructured":"Lyden PD ICTuS-L trial [personal communication] Email to JM Wardlaw"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0666|cit667","first-page":"439","article-title":"Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L) - ongoing trial","volume":"3","author":"Lyden","year":"2008","journal-title":"International Journal of Stroke"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0668|cit668","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1161\/STROKEAHA.107.483131","article-title":"The interventional management of stroke (IMS) II study","volume":"38","author":"The IMS II Trial Investigators","year":"2007","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0669|cit669","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.STR.0000121641.77121.98","article-title":"Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study","volume":"35","author":"The IMS Study Investigators","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0670|cit670","unstructured":"Broderick JP Anderson C Carrozzella J Demchuk AM Dillon C Hill MD The Interventional Management of Stroke (IMS) III trial: an ongoing phase III trial American Heart Association 2008 CT P44"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0671|cit671","first-page":"597","article-title":"Barriers to the emergency use of thrombolysis for acute ischemic stroke: the INcreasing Stroke Treatment through INteractive Behavioural Change Tactics (INSTINCT) Trial","volume":"39","author":"Meurer","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0672|cit672","unstructured":"Scott P Morgenstern L INcreasing Stroke Treatment through INterventional behavior Change Tactics (the INSTINCT Trial) sitemaker.umich.edu\/instinct\/home"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0674|cit673","unstructured":"Scott PA INSTINCT. INcreasing Stroke Treatment through INterventional Behavior Change Tactics www.strokecenter.org\/trials\/TrialDetail.aspx?tid=688"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0673|cit674","unstructured":"Scott PA Silbergleit R Morgenstern LB Haan MN Kalbfleisch JD Cabana MD INcreasing Stroke Treatment through INterventional Behaviour Change Tactics www.abstractsonline.com\/arch\/RecordPrintView.aspx?LookupKey=12345&Re..."},{"key":"10.1002\/14651858.CD000213.pub3-BIB0675|cit675","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1747-4949.2009.00245.x","article-title":"Comment on ITAIS","volume":"4","author":"Donnan","year":"2009","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0680|cit676","unstructured":"Wang Y Imaging-based thrombolysis trial in acute ischemic stroke www.controlled-trials.com 2005"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0676|cit677","first-page":"602","article-title":"Comparison of intravenous and intra-arterial tPA within 3-6 hours guided by multi-MRI: randomised study of 36 patients","volume":"39","author":"Wang","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0677|cit678","unstructured":"Wang Y Jiang W Zhao X Du B Dong K Liao X Imaging-based thrombolysis trial in acute ischemic stroke www.abstractonline.com\/arch\/RecordPrintView.aspx?LookupKey=12345&recordID=17703"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0678|cit679","first-page":"49","article-title":"Imaging-based thrombolysis trial in acute ischemic stroke-II (ITAIS-II)","volume":"4","author":"Wang","year":"2009","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0679|cit680","unstructured":"Wang Y Wang Y ITAIS. Imaging-based thrombolysis trial in acute ischemic stroke www.strokecenter.org\/trials\/TrialDetail.aspx?tid=680"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0681|cit681","first-page":"217","article-title":"Different multi-parametric MRI patterns guide thrombolytic therapy beyond 3h of symptom onset in acute ischemic stroke patients","volume":"3","author":"Wang","year":"2008","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0682|cit682","unstructured":"Wang Y The ITAIS trial [personal communication] Email to JM Wardlaw"},{"issue":"2-4","key":"10.1002\/14651858.CD000213.pub3-BIB0683|cit683","first-page":"213","article-title":"Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase","volume":"23","author":"Jin","year":"2000","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0684|cit684","first-page":"S256","article-title":"Evaluation of intraarterial urokinase therapy in acute stroke","volume":"187 Suppl 1","author":"Kandil","year":"2001","journal-title":"Journal of Neurological Science"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0685|cit685","first-page":"589","article-title":"Partial recanalization after intraarterial thrombolysis: angiographic consequences and clinical outcome","volume":"39","author":"Kim","year":"2008","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0686|cit686","first-page":"187","article-title":"Evaluation of intravenous urokinase, ozagrel sodium and low molecular dextran therapy in acute ischemic stroke - comparison of infusion methods of urokinase","volume":"6","author":"Konta","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0687|cit687","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1747-4949.2012.00901.x","article-title":"A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke","volume":"8","author":"Lang","year":"2013","journal-title":"International Journal of Stroke"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0688|cit688","first-page":"736","article-title":"Clinical observation on effect of tongnao huolo acupuncture therapy in treating acute cerebral infarction at ultra-early or acute stage","volume":"23","author":"Li","year":"2003","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0689|cit689","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/01.STR.0000202582.29510.6b","article-title":"Therapy of basilar artery occlusion. A systematic analysis comparing intra-arterial and intravenous thrombolysis","volume":"37","author":"Lindsberg","year":"2006","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0690|cit690","first-page":"303","article-title":"Efficacy analysis of DUM infusion interventionally on 33 cases of cerebral thrombosis","volume":"11","author":"Liu","year":"1991","journal-title":"Chinese Journal of Practical Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0691|cit691","first-page":"313","article-title":"Randomised controlled trial of Crack Ahylysantifarctase in treating cerebral infarction","volume":"16","author":"Yufeng","year":"1994","journal-title":"Beijing Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0692|cit692","first-page":"504","article-title":"Clinical observation of treatment through intravenous thrombolysis with urokinase for patients with early acute cerebral infarction","volume":"21","author":"Liu","year":"2004","journal-title":"Practical Journal of Medicine and Pharmacy"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0693|cit693","first-page":"42","article-title":"Study of correlation between times of a disease and plasma fibrinogen molecular reactivity in patients with acute cerebral infarction","volume":"7","author":"Lu","year":"2001","journal-title":"Hong Kong Medical Journal"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0695|cit694","unstructured":"Haley EC Pilot study of TNK-TPA in acute ischemic stroke commons.cit.nih.gov\/crisp3...dit_numfound=53&p_keywords=stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0696|cit695","unstructured":"Haley EC TNK in acute ischemic stroke www.strokecenter.org\/trials\/ 2000"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0694|cit696","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.STR.0000154872.73240.e9","article-title":"A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke","volume":"36","author":"Haley","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0697|cit697","first-page":"246","article-title":"Pilot study of tenecteplase (TNK) in acute ischemic stroke: preliminary report","volume":"34","author":"Lyden","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0698|cit698","unstructured":"Lyden P Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke www.ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0699|cit699","unstructured":"Lyden P Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke www.strokecenter.org"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0700|cit700","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.13.11.927","article-title":"Therapeutic thrombolysis in cerebral thromboembolism","volume":"13","author":"Meyer","year":"1963","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0701|cit701","first-page":"373","article-title":"Anticoagulants plus streptokinase therapy in progressing stroke","volume":"189","author":"Meyer","year":"1963","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0702|cit702","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00234-011-0944-1","article-title":"Perfusion-CT guided intravenous thrombolysis in patients with unknown-onset stroke: a randomized, double-blind, placebo-controlled, pilot feasibility trial","volume":"54","author":"Michel","year":"2012","journal-title":"Neuroradiology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0703|cit703","first-page":"271","article-title":"CT-perfusion guided intravenous thrombolysis for unknown onset of stroke symptoms: clinical results of a pilot study","volume":"3","author":"Michel","year":"2008","journal-title":"International Journal of Stroke"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD000213.pub3-BIB0704|cit704","first-page":"77","article-title":"CT-perfusion guided intravenous thrombolysis for unknown onset stroke: clinical and radiological results of a pilot study","volume":"27","author":"Michel","year":"2009","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0706|cit705","unstructured":"Thijs V MITI-IV trial [personal communication] Email to JM Wardlaw"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0707|cit706","unstructured":"Thijs V MITI-IV. Intravenous administration of microplasmin for treatment of acute ischemic stroke www.strokecenter.org\/trials\/TrialDetail.aspx?tid=523"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0705|cit707","unstructured":"Thijs V Vosko Peeters A Aichner F Rother J Pakola S Double blind placebo controlled IV microplasmin administration in patients with acute ischemic stroke Powerpoint Presentation"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0708|cit708","first-page":"82","article-title":"Double-blind, placebo-controlled, intra-venous microplasmin administration in patients with acute ischemic stroke","volume":"3 Suppl 1","author":"Thijs","year":"2008","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0709|cit709","unstructured":"Thijs VN MITI-IV Study Group Intravenous administration of microplasmin for treatment of acute ischemic stoke (MITI-IV) www.abstractsonline.com\/arch\/RecordPrintView.aspx?LookupKey=12345&RecordID=17591"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0710|cit710","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1161\/STROKEAHA.109.560201","article-title":"Randomized, placebo-controlled, dose-ranging clinical trial of intravenous microplasmin in patients with acute ischemic stroke","volume":"40","author":"Thijs","year":"2009","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0711|cit711","unstructured":"ThromboGenics Intravenous administration of microplasmin for treatment of acute ischemic stroke www.clinicaltrials.gov\/ct\/show\/NCT00123305"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0715|cit712","first-page":"15","article-title":"Microbubble-enhanced sonothrombolysis for acute ischemic stroke","volume":"26","author":"Molina","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0712|cit713","first-page":"419","article-title":"Microbubbles administration accelerates clot lysis during continuous 2 MHz ultrasound monitoring in stroke patients treated with intravenous tPA","volume":"36","author":"Molina","year":"2005","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0713|cit714","first-page":"30","article-title":"Microbubbles-enhanced sonothrombolysis for acute ischemic stroke","volume":"19","author":"Molina","year":"2005","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0714|cit715","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.STR.0000199064.94588.39","article-title":"Microbubbles administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator","volume":"37","author":"Molina","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0716|cit716","first-page":"621","article-title":"Efficacy of microbubble-enhanced sonothrombolysis among stroke subtypes","volume":"37","author":"Rubiera","year":"2006","journal-title":"Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0717|cit717","first-page":"39","article-title":"Effects of microbubbles-enhanced sonothrombolysis among stroke subtypes","volume":"21","author":"Rubiera","year":"2006","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0718|cit718","unstructured":"Morris DC Abciximab and rt-PA in acute ischemic stroke treatment www.strokecenter.org\/trials\/TrialDetail.aspx?tid=481"},{"issue":"1-2","key":"10.1002\/14651858.CD000213.pub3-BIB0719|cit719","first-page":"122","article-title":"Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis","volume":"113","author":"Naito","year":"1986","journal-title":"Folia Haematologica (Leipz)"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0720|cit720","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7887\/jcns.6.84","article-title":"Acute thrombolytic therapy for middle cerebral artery occlusion","volume":"6","author":"Ohta","year":"1997","journal-title":"Japanese Journal of Neurosurgery"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0721|cit721","first-page":"e126","article-title":"The effect of intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke","volume":"42","author":"Pan","year":"2011","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0722|cit722","first-page":"229","article-title":"Clinical study of therapeutic effectiveness in treating ischaemic cerebrovascular disease with lumbrokinase","volume":"26","author":"Pang","year":"1993","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0723|cit723","unstructured":"Dippel DWJ Dirks M Niessen L Huijsman R Minkman M Franke C PRACTISE. Promoting acute thrombolysis for ischemic stroke ISRCTN 20405426 www.researchgate.net\/publication\/246838379_Promoting_acute_thrombolysis_for_ischaemic_stroke_(PRACTISE)._Protocol_for_a_cluster_randomised_controlled_trial_to_assess_the_effect_of_implementation_strategies_on_the_rate_and_effects_of_thrombolysis_for_acute_ischaemic_stroke_(ISRCTN_20405426)"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0724|cit724","unstructured":"Dirks M Niessen LW Koudstaal PJ Van Wijngaarden J Minkman M Franke C PRACTISE: Promoting acute thrombolysis for ischemic stroke. A cluster-randomised trial of high intensity versus regular intensity implementation of thrombolysis www.esc-brussels.org\/esc_ongoing_trials.asp"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0725|cit725","unstructured":"Nederlands Trial Register PRACTISE: Promoting acute thrombolysis for ischemic stroke www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=311"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0726|cit726","unstructured":"On behalf of the PRACTISE Investigators Dirks M Niessen L Koudstaal PJ Franke C van Oostenbrugge RJ Huijsman R Indications and contra-indications for intravenous thrombolysis in acute ischemic stroke Unpublished"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0727|cit727","unstructured":"PRACTISE PRACTISE. Promoting acute thrombolysis for ischemic stroke www.practise-trial.org"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0728|cit728","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/qjmed\/hcl020","article-title":"Towards effective and efficient care pathways: thrombolysis in acute ischaemic stroke","volume":"99","author":"Wijngaarden","year":"2006","journal-title":"Quarterly Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0729|cit729","first-page":"16","article-title":"The dynamic study of stroke MRI in hyperacute stroke patients with thrombolysis","volume":"7","author":"Qiang","year":"2001","journal-title":"Hong Kong Medical Journal"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0730|cit730","unstructured":"Qureshi AI Safety and efficacy of intra-arterial reteplase and intravenous Abciximab in patients with acute ischemic stroke www.strokecenter.org\/trials\/TrialDetails.aspx?tid=201"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0731|cit731","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1227\/01.NEU.0000232862.06246.3D","article-title":"Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, Phase 1 study","volume":"59","author":"Qureshi","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0732|cit732","unstructured":"Ribeiro PW Cola PC Gatto AR Silva RG Schelp AO Braga GP Impact of cerebral reperfusion therapy in patients after ischemic stroke: aspects of oral intake evolution Proceedings of the 8th World Stroke Congress. Oct 10-13 2012; Brasilia, Brazil 2012"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0733|cit733","first-page":"A462","article-title":"Safety of combined abciximab and reteplase in acute ischemic stroke: interim results of ReoPro Retavase Reperfusion of Stroke Safety Study Imaging Evaluation (ROSIE)","volume":"62 Suppl 5","author":"Dunn","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0734|cit734","unstructured":"Dunn B Davis LA Todd JW Chalela JA Warach S ROSIE Investigators ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation (ROSIE) www.abstractsonline.com\/arch\/RecordView.aspx?LookupKey=12345&recordID=10974"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0735|cit735","unstructured":"Dunn B Warach S ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation www.abstractsonline.com\/arch\/RecordView.aspx?LookupKey=12345&recordID=16962"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0736|cit736","unstructured":"NCT00039832 ReoPro and retavase to restore brain blood flow after stroke clinicaltrials.gov\/ct\/gui\/show\/NCT00039832"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0737|cit737","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1541-0420.2008.01009.x","article-title":"Patient-specific dose finding based on bivariate outcomes and covariates","volume":"64","author":"Thall","year":"2008","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0740|cit738","unstructured":"Warach S Personal communication"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0741|cit739","unstructured":"Warach S ROSIE. ReoPro Retavase Reperfusion of Stroke Safety Study -- Imaging Evaluation www.strokecenter.org\/trials\/TrialDetail.aspx?tid=462"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0738|cit740","unstructured":"Warach S Butman J Davis L Dunn B Hsia A Latour L ReoPro Retavase Reperfusion in Stroke Safety Study -- Imaging Evaluation (ROSIE): interim safety and efficacy results www.abstractsonline.com\/arch\/RecordView.aspx?LookupKey=12345&recordID=16995"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0739|cit741","unstructured":"Warach S Davis L ROSIE Study Group ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation (ROSIE) The American Stroke Association 28th International Stroke Conference; 2003 Feb 13-15; Phoenix (AZ), USA 2003 CTP40"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0742|cit742","unstructured":"Davis L ROSIE-2. Reperfusion of stroke Safety study Imaging Evaluation - 2 www.strokecenter.org"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0743|cit743","unstructured":"NCT00046293 ReoPro Retavase Reperfusion of Stroke Safety Study-Imaging Evaluation With Computed Tomography (ROSIE-CT) www.clinicaltrials.gov\/ct\/gui\/show\/NCT00046293"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0744|cit744","unstructured":"Warach S ROSIE-CT study [personal communication] Email to JM Wardlaw"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0745|cit745","unstructured":"Warach S ROSIE-CT. ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation with Computed Tomography www.strokecenter.org\/trials\/TrialDetail.aspx?tid=438&printView=true"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0746|cit746","first-page":"260","article-title":"Thrombolysis in patients without MRI mismatch","volume":"34","author":"Rother","year":"2003","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0747|cit747","first-page":"101","article-title":"Clinical study on ultra-early intravenous thrombolysis with high-dose urokinase in treatment of acute cerebral infarction","volume":"80","author":"Shi","year":"2000","journal-title":"National Medical Journal of China"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0748|cit748","first-page":"e217","article-title":"Thrombotripsy study - safety and efficacy of acceleration of thrombolysis by TCCS","volume":"35","author":"Skoloudik","year":"2004","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0749|cit749","first-page":"180","article-title":"Efficacy of sonothrombotripsy versus sonothrombolysis in recanalization of intracranial arteries","volume":"13","author":"Skoloudik","year":"2006","journal-title":"European Journal of Neurology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0750|cit750","first-page":"21","article-title":"T-PA treatment increases circulating endothelial progenitor cells (SPCS) in acute ischemic stroke","volume":"23","author":"Sobrino","year":"2007","journal-title":"Cerebrovascular Diseases"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0751|cit751","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/STROKEAHA.106.465567","article-title":"Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke","volume":"38","author":"Ciccone","year":"2007","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0752|cit752","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnis.2009.001388","article-title":"Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial","volume":"2","author":"Ciccone","year":"2010","journal-title":"Journal of Neurointerventional Surgery"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0754|cit753","unstructured":"Mandzia JL Thrombolysis for minor ischaemic stroke with proven acute symptomatic occlusion using TNK-tPA (TEMPO-1) Proceedings of the 22nd European Stroke Conference. 28-31 May 2013; London, UK 2013 Abst. OAID113"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0753|cit754","unstructured":"Mandzia JL Coutts SB Kenney C Hill MD Thrombolysis for minor ischaemic stroke with proven acute symptomatic occlusion using TNK-tPA (TEMPO-1) Proceedings of the International Stroke Conference 2013. 6-8 February 2013; Honolulu, Hawaii, USA 2013 Abst. CT P18"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0755|cit755","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.STR.0000154872.73240.e9","article-title":"A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke","volume":"36","author":"Haley","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0756|cit756","unstructured":"Wang D Talkad A Beck J Mathews M Jahnel J TNK for ischemic lacunar syndrome - the TNKilas trial American Heart Association 2008 CT P42"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0757|cit757","unstructured":"Haley EC Study of tenecteplase (TNK) in acute ischemic stroke (TNK-S2B) clinicaltrials.gov\/ct\/show\/NCT00252239"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0758|cit758","first-page":"14","article-title":"TNK induces faster MCA recanalization and better short-term outcome than native TPA. The TNK-TPA reperfusion stroke study","volume":"25","author":"Molina","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0759|cit759","first-page":"563","article-title":"TNK induces faster MCS recanalization and leads to better short- and long-term clinical outcome than native tPA. The TNK-TPA reperfusion stroke study","volume":"39","author":"Molina","year":"2008","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0760|cit760","first-page":"71","article-title":"A biological syndrome predictive of cerebral bleeding in rtPA thrombolysis (data from the Lyon thrombolysis registry)","volume":"10","author":"Troullias","year":"2000","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0761|cit761","unstructured":"Del Zoppo G TTATTS Study [personal communication] Email to JM Wardlaw"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0762|cit762","first-page":"133","article-title":"Vastt - the v10153 acute stroke thrombolysis trial","volume":"3 Suppl 1","author":"Hill","year":"2008","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0763|cit763","first-page":"abstract 26","article-title":"VASTT - the V10153 Acute Stroke Thrombolysis Trial","volume":"24","author":"Hill","year":"2007","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0764|cit764","unstructured":"Hill MD VASTT. The V10153 acute stroke thrombolysis trial www.strokecenter.org\/trials\/TrialDetail.aspx?tid=735"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0765|cit765","first-page":"45","article-title":"VASTT - The V10153 Acute Stroke Thrombolysis Trial","volume":"1 Suppl 2","author":"Pawsey","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0766|cit766","unstructured":"Vernalis Development Safety and efficacy study in acute ischaemic stroke www.clinicaltrials.gov (accessed 2007)"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0767|cit767","unstructured":"Vernalis Thrombotic disease: V10153 www.vernalis.com\/ver\/rdc2\/neurology\/v10153"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0768|cit768","first-page":"65","article-title":"A randomized, double-blind, placebo-controlled clinical trial of lumbrokinase capsules on the patients of blood rheology disorders with ischemic cerebrovascular diseases","volume":"13","author":"Wang","year":"1997","journal-title":"Chinese Journal of Clinical Pharmacology"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0769|cit769","first-page":"485","article-title":"Observations of effect of defibrase in treatment of 30 cases with acute cerebral thrombosis","volume":"19","author":"Wang","year":"1999","journal-title":"Chinese Journal of Critical Care Medicine"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0770|cit770","unstructured":"Xiang ZY Thrombolytic therapy and external counterpulsation in acute cerebral infarction Proceedings of the 4th Chinese Stroke Conference; 1995 Oct; Chengdu 1995 44"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0771|cit771","first-page":"35","article-title":"Acute cerebral infarction treated by ahylsantinfarctase acupuncture: report of 60 cases","volume":"12","author":"Xu","year":"1997","journal-title":"Forum on Traditional Chinese Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0772|cit772","first-page":"124","article-title":"Comparison of the curative effects between ahylysantinfarctase and difibrinogenase on cerebral infarction","volume":"30","author":"Xu","year":"2000","journal-title":"Journal of Wenzhou Medical College"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0773|cit773","first-page":"359","article-title":"Clinical study on urokinase and nimodipine intravenous thrombolysis in acute cerebral infarction","volume":"20","author":"Xu","year":"2004","journal-title":"Chinese Pharmacological Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0774|cit774","first-page":"111","article-title":"High dose urokinase in the treatment of acute ischaemic stroke","volume":"3","author":"Yuan","year":"1995","journal-title":"Journal of Brain and Neurological Diseases"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub3-BIB0775|cit775","first-page":"790","article-title":"Intravenous thrombolysis with urokinase in treating acute cerebral infarctions","volume":"24","author":"Zhang","year":"2003","journal-title":"Sichuan Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0776|cit776","first-page":"191","article-title":"Functions changes of VEC and therapeutic effect on VEC in patients with acute cerebral infarct","volume":"3","author":"Zhou","year":"1996","journal-title":"Zuzhong Yu Shenjing Jibing"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0777|cit777","unstructured":"Berge E Results of the FRALYSE randomized study: effect of the duration of rt-PA infusion on the functional outcome in patients with acute cerebral infarct [personal communication] Email to JM Wardlaw"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0778|cit778","first-page":"924","article-title":"Effects of intravenous thrombolysis in treatment of acute cerebral infraction at early stage","volume":"15","author":"Lin","year":"2006","journal-title":"Chinese Journal of Emergency Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0779|cit779","first-page":"135","article-title":"Intravenous thrombolysis with rt-PA in acute stroke patients aged >80 years: the TESPI study","volume":"3","author":"Lorenzano","year":"2008","journal-title":"International Journal of Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0780|cit780","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1747-4949.2011.00747.x","article-title":"TESPI (thrombolysis in elderly stroke patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset","volume":"7","author":"Lorenzano","year":"2012","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0781|cit781","unstructured":"Toni D A randomised trial of alteplase in acute stroke www.agenziafarmaco.it"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0782|cit782","unstructured":"Toni D A randomized controlled trial of alteplase (rt-PA) vs standard treatment in acute ischemic hemispheric stroke in patients aged more than 80 years, where thrombolysis is initiated within 3 hours after stroke onset www.agenziafarmaco.it"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0783|cit783","unstructured":"Toni D TESPI study [personal communication] Email to JM Wardlaw"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0784|cit784","unstructured":"Toni D TESPI. Thrombolysis in Elderly Stroke Patients in Italy www.strokecenter.org\/trials\/"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0785|cit785","unstructured":"Der Hoeven EJRJ Schonewille WJ Vos JA BASICS Trial. Basilar Artery International Cooperation Study Research Protocol www.basicstrial.com\/Protocol.html 2012"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0786|cit786","unstructured":"Albers G Von Kummer R Desmoteplase in Acute Ischemic Stroke: Phase III twin trials Proceedings of the International Stroke Conference 2009; 2009 Feb 18-20; San Diego (CA), USA 2009 CT P19"},{"issue":"Meeting Abstrac","key":"10.1002\/14651858.CD000213.pub3-BIB0787|cit787","first-page":"P07.249","article-title":"The desmoteplase DIAS-3 and DIAS-4 clinical trials: a status update","volume":"80","author":"Albers","year":"2013","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0788|cit788","unstructured":"Albers GW Von Kummer R Desmoteplase 3-9 hours after Acute Ischemic Stroke: an update on the DIAS clinical trial program Proceedings of the International Stroke Conference 2010; 2010 Feb 24-26; San Antonio (TX) USA 2010 CT P5"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0789|cit789","unstructured":"Albers GW Von Kummer R Desmoteplase 3-9 hours after Acute Ischemic Stroke: the ongoing DIAS-3 and DIAS-4 clinical trials Proceedings of the International Stroke Conference 2012; 2012 Feb 1-3; New Orleans (LA), USA 2012 CT P21"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0790|cit790","unstructured":"Albers GW Von Kummer R Desmoteplase in Acute Ischemic Stroke: status update on the DIAS clinical trial program Proceedings of the International Stroke Conference 2011; 2011 Feb 8-11; Los Angeles (CA), USA 2011 CTP16"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0791|cit791","unstructured":"Albers GW Von Kummer R: DIAS-3 and DIAS-4 Study Group The desmoteplase DIAS-3 and DIAS-4 clinical trials: an important milestone passed Proceedings of the 8th World Stroke Congress; 2013 Oct 10-13; Brasilia, Brazil 2013 Abst. 98"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0792|cit792","unstructured":"Albers GW Von Kummer R the DIAS-3 and DIAS-4 Study Group The desmoteplase DIAS-3 and DIAS-4 clinical trials: background and status update Proceedings of the International Stroke Conference 2013; 2013 Feb 6-8 ; Honolulu (HI), USA 2013 CT P3"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0793|cit793","unstructured":"Lundbeck H DIAS-3. Efficacy and safety study of desmoteplase to treat acute ischemic stroke www.strokecenter.org\/trials\/"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0794|cit794","unstructured":"Lundbeck H Efficacy and safety study of desmoteplase to treat acute ischemic stroke (DIAS-3) www.ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0798|cit795","unstructured":"Von Kummer R The desmoteplase clinical trial programme: DIAS-3 is nearing completion Proceedings of the 22nd European Stroke Conference; 2013 May 28-31; London, UK 2013 Abst. OAID59"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0795|cit796","unstructured":"Von Kummer R Albers G Desmoteplase In Acute Stroke 3 and 4, DIAS-3 and DIAS-4, phase III twin trials Proceedings of the 18th European Stroke Conference 2009; 2009 May 26-29; Stockholm, Sweden 2009 Abst. OAID 5"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0797|cit797","unstructured":"Von Kummer R Albers GW The Desmoteplase DIAS-3 and DIAS-4 clinical trials: an important milestone passed Proceedings of the 21st European Stroke Conference; 2012 May 22-25; Lisbon, Portugal 2012 Abst. OAID 37"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0796|cit798","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1747-4949.2012.00910.x","article-title":"The desmoteplase in acute ischemic stroke (DIAS) clinical trial program","volume":"7","author":"Kummer","year":"2012","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0799|cit799","unstructured":"Albers G Von Kummer R Desmoteplase in Acute Ischemic Stroke: Phase III twin trials Proceedings of the International Stroke Conference 2009; 2009 Feb 18-20; San Diego (CA), USA 2009 CT P19"},{"issue":"Meeting Abstrac","key":"10.1002\/14651858.CD000213.pub3-BIB0800|cit800","first-page":"P07.249","article-title":"The desmoteplase DIAS-3 and DIAS-4 clinical trials: A status update","volume":"80","author":"Albers","year":"2013","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0801|cit801","unstructured":"Albers GW Von Kummer R Desmoteplase 3-9 hours after Acute Ischemic Stroke: an update on the DIAS clinical trial program Proceedings of the International Stroke Conference 2010; 2010 Feb 24-26; San Antonio (TX), USA 2010 CT P5"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0802|cit802","unstructured":"Albers GW Von Kummer R Desmoteplase 3-9 hours after Acute Ischemic Stroke: the ongoing DIAS-3 and DIAS-4 clinical trials Proceedings of the International Stroke Conference 2012; 2012 Feb 1-3; New Orleans (LA), USA 2012 CT P21"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0803|cit803","unstructured":"Albers GW Von Kummer R Desmoteplase in Acute Ischemic Stroke: status update on the DIAS clinical trial program Proceedings of the International Stroke Conference 2011; 2011 Feb 8-11; Los Angeles (CA), USA 2011 CTP16"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0804|cit804","unstructured":"Albers GW Von Kummer R DIAS-3 and DIAS-4 Study Group The desmoteplase DIAS-3 and DIAS-4 clinical trials: an important milestone passed Proceedings of the 8th World Stroke Congress; 2013 Oct 10-13; Brasilia, Brazil 2013 Abst. 98"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0805|cit805","unstructured":"Albers GW Von Kummer R the DIAS-3 and DIAS-4 Study Group The desmoteplase DIAS-3 and DIAS-4 clinical trials: background and status update Proceedings of the International Stroke Conference 2013; 2013 Feb 6-8; Honolulu (HI), USA 2013 CT P3"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0806|cit806","unstructured":"Gorelick PB Albers GW Von Kummer R Desmoteplase in Acute Ischemic Stroke (DIAS) clinical trial program: regional hub-spoke recruitment in DIAS-4 in the United States Proceedings of the International Stroke Conference 2011; 2011 Feb 8-11; Los Angeles (CA), USA 2011 CTP39"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0807|cit807","unstructured":"H Lundbeck A\/S Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4) www.ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0811|cit808","unstructured":"Von Kummer R The desmoteplase clinical trial programme: DIAS-3 is nearing completion Proceedings of the 22nd European Stroke Conference. 2013 May 28-31; London, UK 2013 Abst. OAID59"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0808|cit809","unstructured":"Von Kummer R Albers G Desmoteplase In Acute Stroke 3 and 4, DIAS-3 and DIAS-4, phase III twin trials Proceedings of the 18th European Stroke Conference 2009; 2009 May 26-29; Stockholm, Sweden 2009 Abst. OAID 5"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0810|cit810","unstructured":"Von Kummer R Albers GW The Desmoteplase DIAS-3 and DIAS-4 clinical trials: an important milestone passed Proceedings of the 21st European Stroke Conference; 2012 May 22-25; Lisbon, Portugal 2012 Abst. OAID 37"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0809|cit811","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1747-4949.2012.00910.x","article-title":"The desmoteplase in acute ischemic stroke (DIAS) clinical trial program","volume":"7","author":"Kummer","year":"2012","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0812|cit812","unstructured":"Lundbeck Japan KK Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke (DIAS-J) www.ClinicalTrials.gov"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213.pub3-BIB0813|cit813","first-page":"192","article-title":"Desmoteplase in Japanese patients with acute ischaemic stroke (DIAS-J): study objectives of a randomised, double-blind, placebo-controlled, dose escalation trial","volume":"5","author":"Mori","year":"2010","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0814|cit814","unstructured":"Penner R Paion`s partner Lundbeck initiates Japanese clinical phase II trial with desmoteplase in ischaemic stroke www.paion.de\/images\/stories\/investoren\/finanznachrichten\/2010\/en\/pm_dias-j_enfinal.pdf 2010"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub3-BIB0815|cit815","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1747-4949.2012.00910.x","article-title":"The desmoteplase in acute ischemic stroke (DIAS) clinical trial program","volume":"7","author":"Kummer","year":"2012","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0816|cit816","first-page":"52","article-title":"EXtending the time for Thombolysis in Emergency Neurological Deficits - The EXTEND Trial progress","volume":"7","author":"Campbell","year":"2012","journal-title":"International Journal of Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0817|cit817","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1747-4949.2012.00787.x","article-title":"Multiattribute selection of acute stroke imaging software platform for extending the time for thrombolysis in emergency neurological deficits (EXTEND) clinical trial","volume":"8","author":"Churilov","year":"2013","journal-title":"International Journal of Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0818|cit818","first-page":"61","article-title":"Recruitment to trials of late thrombolysis","volume":"7","author":"Dagonnier","year":"2012","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0823|cit819","unstructured":"Donnan G EXTEND : Extending the time for Thrombolysis in Emergency Neurological Deficits www.anzctr.org.au\/"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0821|cit820","unstructured":"Donnan G Davis S START-EXTEND. STroke imAging pRevention and Treatment-Extending the time for Thrombolysis in Emergency Neurological Deficits www.strokecenter.org\/trials\/"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0822|cit821","unstructured":"Donnan G Davis S START-EXTEND. Stroke Imaging Prevention And Treatment - Extending The Time For Thrombolysis In Emergency Neurological Deficits www.strokecenter.org\/trials\/"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0819|cit822","first-page":"36","article-title":"EXtending the time for Thrombolysis in Emergency Neurological Deficits - the EXTEND trial progress","volume":"6","author":"Donnan","year":"2011","journal-title":"International Journal of Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0820|cit823","first-page":"40","article-title":"Extending the time for thombolysis in emergency neurological deficits-the extend trial rationale and protocol","volume":"5","author":"Donnan","year":"2010","journal-title":"International Journal of Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0824|cit824","first-page":"A84","article-title":"What's next for the ischaemic penumbra: life after EPITHET","volume":"38","author":"Donnan","year":"2008","journal-title":"Internal Medicine Journal"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0825|cit825","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1747-4949.2011.00730.x","article-title":"A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND)","volume":"7","author":"Ma","year":"2012","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0826|cit826","unstructured":"Intra-arterial urokinase trial Ongoing study April 2002"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0827|cit827","unstructured":"PROACT III Ongoing study"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0828|cit828","unstructured":"Anonymous The WAKE-UP clinical trial www.stroke.org.uk\/research\/wake-clinical-trial 2013"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0830|cit829","unstructured":"Thomalla G A multicentre, randomized, double-blind, placebo-controlled trial to test efficacy and safety of MRI-based thrombolysis in wake-up stroke (WAKE-UP) Proceedings of the 22nd European Stroke Conference; 2013 May 28-31; London, UK 2013 Abst. OAID54"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0831|cit830","unstructured":"Thomalla G Efficacy and safety of MRI-based thrombolysis in wake-up stroke (WAKE-UP) www.ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0832|cit831","unstructured":"Thomalla G Efficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trial www.clinicaltrialsregister.eu"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub3-BIB0829|cit832","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00115-012-3532-7","article-title":"EU-funded treatment study: WAKE-UP. A randomized, placebo-controlled MRI-based trial of thrombolysis in wake-up stroke","volume":"83","author":"Thomalla","year":"2012","journal-title":"Der Nervenart"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0833|cit833","doi-asserted-by":"crossref","first-page":"A77","DOI":"10.1136\/neurintsurg-2012-010455c.72","article-title":"Wake up symptomatic stroke in acute brain ischemia (WASSABI) clinical trial","volume":"4","author":"Kass-Hout","year":"2012","journal-title":"Journal of Neurointerventional Surgery"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0834|cit834","unstructured":"Unknown Ongoing study"},{"issue":"6923","key":"10.1002\/14651858.CD000213.pub3-BIB0835|cit835","first-page":"81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"BMJ"},{"issue":"9131","key":"10.1002\/14651858.CD000213.pub3-BIB0836|cit836","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(05)60007-4","article-title":"Risk of aspirin use plus thrombolysis after acute ischaemic stroke: a further MAST-I analysis. MAST-I Collaborative Group. Multicentre Acute Stroke Trial--Italy","volume":"352","author":"Ciccone","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0837|cit837","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in metaanalysis","volume-title":"Systematic Reviews in Health Care: Metaanalysis in Context","author":"Deeks","year":"2001"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0838|cit838","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/qjmed\/hcg016","article-title":"Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review","volume":"96","author":"Dundar","year":"2003","journal-title":"Quarterly Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0839|cit839","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000131083","article-title":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008","volume":"25","author":"The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"7414","key":"10.1002\/14651858.CD000213.pub3-BIB0840|cit840","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0841|cit841","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213.pub3-BIB0842|cit842","first-page":"125","article-title":"Initial findings of the rt-PA acute stroke treatment review panel","volume":"16","author":"Ingall","year":"2003","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0843|cit843","first-page":"57","article-title":"Meta analysis of thrombolytic therapy of intravenous urokinase in acute cerebral infarction","volume":"9","author":"Jin","year":"2000","journal-title":"Chinese Journal of Pharmacoepidemiology"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0844|cit844","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/01.STR.0000150515.15576.29","article-title":"Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke. A pooled analysis of randomized clinical trials","volume":"36","author":"Kent","year":"2005","journal-title":"Stroke"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0845|cit845","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1161\/01.STR.0000190010.73274.e0","article-title":"Gender differences in tPA-related arterial recanalization (response)","volume":"36","author":"Kent","year":"2005","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0846|cit846","first-page":"455","article-title":"Glycemic index predicts poor prognosis and risk of thrombolytic-related symptomatic intracerebral hemorrhage but does not appear to modify the effectiveness of rtPA therapy","volume":"38","author":"Kent","year":"2007","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0847|cit847","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.STR.0000164484.06950.77","article-title":"Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke","volume":"36","author":"Mann","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0848|cit848","unstructured":"National Institute for Health and Clinical Excellence (NICE) Stroke. The diagnosis and acute management of stroke and transient ischaemic attacks National Institute of Clinical Excellence, www.dh.gov.uk\/stroke 2008 1 37"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0849|cit849","unstructured":"The Nordic Cochrane Centre. The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"9411","key":"10.1002\/14651858.CD000213.pub3-BIB0850|cit850","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","article-title":"Better outcome with early stroke treatment: a pooled analysis of the ATLANTIS, ECASS and NINDS rt-PA stroke trials","volume":"363","author":"Hacke","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0851|cit851","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(10)60491-6","article-title":"Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS and Epithet trials","volume":"375","author":"Lees","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0852|cit852","volume-title":"A systematic review of the effectiveness, cost-effectiveness and barriers to the implementation of thrombolytic and neuroprotective treatment in the NHS","author":"Sandercock","year":"2002"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub3-BIB0853|cit853","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.STR.0000237086.85164.92","article-title":"Sex-based differences in the effect of intra-arterial treatment of stroke: a plea to stop torturing the old data and do large trials!","volume":"37","author":"Sandercock","year":"2006","journal-title":"Stroke"},{"issue":"7059","key":"10.1002\/14651858.CD000213.pub3-BIB0854|cit854","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/bmj.313.7059.735","article-title":"The relation between treatment benefit and underlying risk in meta-analysis","volume":"313","author":"Sharp","year":"1996","journal-title":"BMJ"},{"issue":"9558","key":"10.1002\/14651858.CD000213.pub3-BIB0855|cit855","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","article-title":"Thrombolysis for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study","volume":"369","author":"Wahlgren","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0856|cit856","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0967-5868(99)90596-9","article-title":"Thrombolysis in acute stroke pooling project: a meta-analysis on individual patient data","volume":"6","author":"Cornu","year":"1999","journal-title":"Journal of Clinical Neuroscience"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0857|cit857","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/ijs.12040","article-title":"Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: Statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analysis","volume":"8","author":"Emberson","year":"2013","journal-title":"International Journal of Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0858|cit858","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.STR.0000016923.99605.75","article-title":"Brain haemorrhage after thrombolysis: good or bad?","volume":"33","author":"Kummer","year":"2002","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0859|cit859","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s004150050512","article-title":"The influence of baseline prognostic variables on outcome after thrombolysis. MAST-Italy Collaborative Group","volume":"246","author":"Wardlaw","year":"1999","journal-title":"Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0860|cit860","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/01.STR.31.5.1133","article-title":"Trials of thrombolysis in acute ischaemic stroke: does the choice of primary outcome measure really matter?","volume":"31","author":"Wardlaw","year":"2000","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0861|cit861","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/ewjm.176.3.198","article-title":"Thrombolysis for acute ischaemic stroke: still a treatment for the few by the few","volume":"176","author":"Wardlaw","year":"2002","journal-title":"Western Journal of Medicine"},{"issue":"9834","key":"10.1002\/14651858.CD000213.pub3-BIB0862|cit862","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/S0140-6736(12)60738-7","article-title":"Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis","volume":"379","author":"Wardlaw","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub3-BIB0863|cit863","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000514.pub3","article-title":"Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke","author":"Wardlaw","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0864|cit864","doi-asserted-by":"crossref","DOI":"10.1002\/9780470696361","volume-title":"Stroke: Practical Management","author":"Warlow","year":"2008"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub3-BIB0865|cit865","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/STROKEAHA.112.665331","article-title":"Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies","volume":"43","author":"Whiteley","year":"2012","journal-title":"Stroke"},{"issue":"9843","key":"10.1002\/14651858.CD000213.pub3-BIB0866|cit866","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(12)60949-0","article-title":"Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: A randomised controlled trial","volume":"380","author":"Zinkstok","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0867|cit867","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.STR.23.12.1826","article-title":"Thrombolysis in acute ischemic stroke: does it work?","volume":"23","author":"Wardlaw","year":"1992","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub3-BIB0868|cit868","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000213","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"1995","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub3-BIB0869|cit869","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/ACPJC-1997-126-2-035","article-title":"Meta-analysis: thrombolytic therapy increases the risk for early death and intracranial hemorrhage after acute ischemic stroke","volume":"126","author":"Wardlaw","year":"1997","journal-title":"ACP Journal Club"},{"key":"10.1002\/14651858.CD000213.pub3-BIB0870|cit870","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(97)03022-5","article-title":"Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke","volume":"350","author":"Wardlaw","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub3-BIB0871|cit871","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000213","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub3-BIB0872|cit872","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/01.STR.0000072513.72262.7E","article-title":"Thrombolytic therapy with rt-PA for acute ischaemic stroke: where do we go from here? A cumulative meta-analysis","volume":"34","author":"Wardlaw","year":"2003","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub3-BIB0873|cit873","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000213","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub3-BIB0874|cit874","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1161\/01.STR.0000147964.46510.25","article-title":"Thrombolysis for acute ischemic stroke","volume":"35","author":"Wardlaw","year":"2004","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213.pub3-BIB0875|cit875","first-page":"50","article-title":"Thrombolysis for acute ischaemic stroke. An update of the Cochrane thrombolysis metaanalysis","volume":"3","author":"Wardlaw","year":"2008","journal-title":"International Journal of Stroke"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000213.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T23:30:27Z","timestamp":1684798227000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000213.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,29]]},"references-count":876,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000213.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,29]]}}}